Molekulare und immunologische Charakterisierung von Profilin aus Weizen (Triticum aestivum) by Forstenlechner, Peter
1 
 
 
 
 
 
 
DIPLOMARBEIT 
 
 
 
Molekulare und immunologische Charakterisierung von 
Profilin aus Weizen (Triticum aestivum) 
 
 
 
angestrebter akademischer Grad 
 
Magister der Naturwissenschaften (Mag. rer.nat.)  
 
 
 
Verfasserin / Verfasser: Peter Forstenlechner 
Matrikel-Nummer: 9702904 
Studienrichtung (lt. 
Studienblatt): 
Genetik/Mikrobiologie 
Betreuerin / Betreuer: Ao.Univ.- Prof.Mag.Dr. Pavel Kovarik 
 
 
 
Wien, am  
 
 
 
2 
 
 
 
 
 
 
 
 
 
 
Molecular and immunological 
characterisation of profilin from wheat 
(Triticum aestivum) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
Danksagung 
 
Der experimentelle Teil dieser Arbeit wurde an der Abteilung für medizinische 
Biotechnologie von ao. Prof. Dr. Heimo Breiteneder am Zentrum für Physiologie und 
Pathophysiologie der Medizinischen Universität Wien unter der Anleitung von Univ. 
Doz. Dr. Karin Hoffmann-Sommergruber durchgeführt. 
 
Univ. Doz. Dr. Karin Hoffmann-Sommergruber danke ich für die Möglichkeit der 
Durchführung dieser Diplomarbeit an diesem Zentrum. 
 
Ein ganz großes Dankeschön an alle Laborkollegen des Lab 11 und 16, die mir oft 
genug weitergeholfen haben. 
 
Meinen Eltern und meinem Bruder möchte ich ganz besonders für die moralische 
und finanzielle Unterstützung, auch in äußert schwierigen Zeiten, danken. 
 
Meiner Freundin Nina danke ich für die hochwillkommenen Ablenkungen vom 
wissenschaftlichen Arbeitsalltag. 
 
  
 
 
 
 
 
 
4 
 
 
I. INTRODUCTION ..................................................................................................... 8 
1. Hypersensitivity ................................................................................................... 8 
1.1 Coombs and Gell classification...................................................................... 8 
1.2 Allergy (Type I Hypersensitivity) .................................................................... 8 
1.2.1 Sensitisation ............................................................................................... 8 
1.2.2 Early phase reaction ................................................................................... 9 
1.2.3 Late phase reaction .................................................................................... 9 
2. Food allergy ........................................................................................................ 9 
2.1 Prevalence and classification ........................................................................ 9 
2.2 Symptoms ................................................................................................... 11 
2.2.1 Oral allergy syndrome (OAS) & skin ..................................................... 11 
2.2.2 Respiratory disorders ............................................................................ 12 
2.2.3 Gastrointestinal disorders ..................................................................... 12 
2.2.4 Anaphylaxis ........................................................................................... 12 
2.3 Food allergens ............................................................................................. 13 
2.3.1 Protein families ..................................................................................... 13 
2.3.2 Profilin ................................................................................................... 14 
2.3.3 Cross reactivity ..................................................................................... 15 
3. Wheat ................................................................................................................ 15 
3.1 The history of wheat .................................................................................... 15 
3.2 Wheat related diseases ............................................................................... 16 
3.2.1 Wheat allergens .................................................................................... 16 
3.2.2 Celiac disease ....................................................................................... 17 
3.2.3 Wheat food allergy ................................................................................ 18 
3.2.4 Bakers’ Asthma ..................................................................................... 18 
3.2.5 Wheat dependant exercise induced anaphylaxis (WDEIA) ................... 18 
4. Allergy diagnosis ............................................................................................... 18 
5 
 
4.1 Current diagnostic tools ............................................................................... 18 
4.1.1 In vivo tests ........................................................................................... 18 
4.1.2 Food challenges .................................................................................... 19 
4.2 In vitro tests.............................................................................................. 19 
4.2.1 Assays for specific IgE antibodies ......................................................... 19 
4.3 Recombinant allergens ............................................................................ 19 
5. Aim of the study ................................................................................................ 20 
II. MATERIALS & METHODS ................................................................................... 21 
1. Cloning .............................................................................................................. 21 
1.1 Overview ..................................................................................................... 21 
1.2 Buffers & Solutions ...................................................................................... 22 
1.3 Plant material............................................................................................... 22 
1.4 RNA isolation ............................................................................................... 23 
1.5 RNA Quality Control .................................................................................... 24 
1.5.1 Photometry............................................................................................ 24 
1.5.2 RNA agarose gel electrophoresis ......................................................... 24 
1.6 Complementary DNA first strand synthesis (RT-PCR) ................................ 25 
1.7 PCR ............................................................................................................. 27 
1.7.1 Primer Design ....................................................................................... 27 
1.7.2 PCR reaction ......................................................................................... 28 
1.7.3 PCR program: ....................................................................................... 29 
1.8 Agarose gel electrophoresis ........................................................................ 29 
1.9 Gel extraction .............................................................................................. 30 
1.9.1 QIAGEN QIAEX II – Gel Extraction Kit ................................................. 30 
1.9.2 PCR of gel extraction products (Gelex PCR) ........................................ 31 
1.9.3 Agarose gel electrophoresis of Gelex PCR ........................................... 31 
1.10 Cloning: ligation & transformation .............................................................. 31 
1.10.1 Ligation ............................................................................................... 32 
6 
 
1.10.2 Transformation .................................................................................... 32 
1.11 Colony screening ....................................................................................... 33 
1.12 Plasmid DNA preparation .......................................................................... 33 
1.13 EcoRI Digestion ......................................................................................... 35 
1.14 Sequencing ............................................................................................... 36 
1.14.1 Sequencing PCR ................................................................................ 37 
1.14.2 Sequencing gel electrophoresis (41 cm gel) ....................................... 38 
1.14.3 Data analysis ...................................................................................... 40 
2. Expression ........................................................................................................ 41 
2.1 Overview ..................................................................................................... 41 
2.2 Buffers & Solutions ...................................................................................... 42 
2.3 Expression System ...................................................................................... 42 
2.3.1 Restriction sites-PCR ............................................................................ 42 
2.3.2 Competent cells (E. coli  BL21(DE3) & E. coli  Nova Blue) ................... 44 
2.3.3 Double Digest ....................................................................................... 45 
2.3.4 Dephosphorylation ................................................................................ 46 
2.3.5 Ligation ................................................................................................. 47 
2.3.6 Small Scale Expression Study .............................................................. 48 
2.3.7 Fermentation ......................................................................................... 49 
3. Purification ........................................................................................................ 50 
3.1 Overview ..................................................................................................... 50 
3.2 Buffers & Solutions ...................................................................................... 51 
3.2.1 Column preparation buffers................................................................... 51 
3.2.2 Protein purification buffers .................................................................... 51 
3.2.3 Refolding buffers ................................................................................... 51 
3.3 French Press ............................................................................................... 52 
3.4 Affinity Chromatography .............................................................................. 52 
3.5 Dialysis ........................................................................................................ 55 
7 
 
4. Characterisation ................................................................................................ 56 
4.1 Overview ..................................................................................................... 56 
4.2 Buffers & Solutions ...................................................................................... 56 
4.3 Characterisation .......................................................................................... 57 
4.3.1 SDS-PAGE ........................................................................................... 57 
4.3.2 Bicinchoninic acid protein assay ........................................................... 59 
4.3.3 Limulus amebocyte lysate test .............................................................. 60 
4.3.4 Circular Dichroism ................................................................................. 61 
4.3.5 N-terminal sequencing .......................................................................... 62 
4.3.6 Mass Spectrometry ............................................................................... 63 
4.3.7 IgE blot .................................................................................................. 65 
4.3.8 IgE Inhibition ......................................................................................... 66 
4.3.9 IgE ELISA ............................................................................................. 67 
4.3.10 Sera .................................................................................................... 68 
III. RESULTS ........................................................................................................ 70 
1. Cloning .......................................................................................................... 70 
1.1 Sequence analysis ................................................................................... 73 
2. Expression ..................................................................................................... 75 
3. Purification ..................................................................................................... 77 
4. Characterisation ............................................................................................ 79 
IV. DISCUSSION .................................................................................................. 86 
V. ABBREVIATIONS ............................................................................................. 89 
VI. REFERENCES ................................................................................................ 91 
VII. ZUSAMMENFASSUNG ................................................................................ 100 
VIII. ABSTRACT ................................................................................................. 101 
IX. CURRICULUM VITAE ................................................................................... 102 
INTRODUCTION 
 
8 
 
I. INTRODUCTION 
1. Hypersensitivity 
In 1906 Clemens von Pirquet coined the term allergy. He described allergy as an 
altered capacity of the body to react to a foreign substance. This rather broad 
definition was replaced by a more accurate one: an allergy is a disease following a 
response by the immune system to an otherwise innocuous antigen [1].  
Allergies fall into a group of immune responses called hypersensitivity reactions (tab. 
1).  
1.1 Coombs and Gell classification  
Coombs and Gell divided Hypersensitivity reactions into four groups: 
 Type I Type II Type III Type IV 
Immune reactant IgE IgG, IgM IgG, IgM TH1 cells TH2 cells CTL 
Antigen Soluble 
antigen 
Cell- or matrix 
associated 
antigen 
Cell 
surface 
receptor 
Soluble 
antigen 
Soluble 
antigen 
Soluble 
antigen 
Cell-
associated 
antigen 
Effector 
mechanism 
Mast-cell 
activation 
Complement, 
FcR+ cells 
Antibody 
alters 
signalling 
Complement, 
Phagocytes 
Macrophage 
activation 
IgE 
production, 
Eosinophil 
activation, 
Mastocytosis 
Cytotoxicity 
Example of 
hypersensitivity 
reaction 
Allergic 
rhinitis, 
asthma, 
systemic 
anaphylaxis 
Penicillin- and 
other drug 
allergy 
Chronic 
urticaria 
Serum 
sickness, 
Arthus 
reaction 
Contact 
dermatitis, 
tuberculin 
reaction 
Chronic 
asthma, 
chronic 
allergic rhinitis 
Contact 
dermatitis 
Tab. 1: Coombs and Gell classification of hypersensitivity reactions [1] 
 
1.2 Allergy (Type I Hypersensitivity) 
During the first encounter between immune system and allergen, allergen specific 
IgE antibodies are produced. These antibodies occupy the FcεR1 receptor on mast 
cells and basophil granulocytes. If the allergen is able to crosslink specific IgEs 
during the second encounter, the mast cells (basophils) degranulate and the allergic 
reaction takes its course. The pathophysiological mechanism of allergy falls into three 
stages: sensitisation, early phase- and late phase reaction. 
 
1.2.1 Sensitisation 
Is the allergen able to enter the body and encounter an antigen presenting cell (e.g. 
dendritic cell), this cell will take up and process the allergen. This is followed by the 
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presentation of parts of the allergen to a naive T-cell (CD4+), which differentiates into 
a TH2 cell. This TH2 cell starts to produce interleukin 4 (IL-4), a cytokine that forces B-
cells to differentiate into an antibody producing plasma cell. After class switch from 
IgM to IgE, the antigen specific antibodies (IgE) enter circulation and spread 
throughout the body to bind the high affinity receptors (FcεRI) on mast cells 
(basophils). During this process no symptoms occur [1]. 
1.2.2 Early phase reaction 
If the immune system of the sensitised person encounters the allergen a second 
time, the bound IgEs on mast cells (basophils) crosslink via the allergen and trigger a 
cellular signal cascade. This leads to the degranulation of mast cells (basophils). In 
this process, preformed mediators, such as histamine, tryptases, kininogenase and 
ECF-A (Eosinophil Chemotactic Factor for Anaphylaxis) are released. Within a short 
period of time (30 minutes) these molecules lead to symptoms such as conjunctivitis, 
rhinitis, broncho-constriction, gastrointestinal reactions or even to an anaphylactic 
shock [1]. 
1.2.3 Late phase reaction 
Not all mediators are stored in the granulae of mast cells (basophils), some are newly 
formed. Potent mediators like leukotrienes (e.g. B4, C4, D4), prostaglandin D2 and PAF 
are newly synthesized and drive the inflammatory reaction even further. Two to 
twenty four hours after exposure to the allergen, macrophages, TH2-cells, 
eosinophils, and neutrophils join the reaction. Eosinophils and neutrophils release 
hydrolytic enzymes, which lead to necrosis [2].  
If the allergic person is not exposed to the allergen source permanently, the 
symptoms will subside in time [1]. 
 
2. Food allergy 
2.1 Prevalence and classification 
In first world countries 2-4% [3] of adults and 6-8% [4] of children suffer from food 
allergy. IgE mediated food allergies have to be distinguished from other adverse food 
reactions caused by non allergic mechanisms. The most prominent non-allergic 
adverse food reaction is food intolerance towards lactose. For the correct diagnosis 
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of food allergy it is essential to distinguish between the different types of adverse 
food reactions. For this reason the European Academy of Allergology and Clinical 
Immunology (EAACI) developed a classification system (fig. 1). 
 
 
Fig. 1: EAACI classification of adverse food reactions [5]. 
 
Adverse food reactions can be divided into toxic and non toxic reactions. Toxic 
reactions affect every person exposed to the culprit food (e.g. Salmonella poisoning). 
Non-toxic reactions are divided into food allergies and food intolerances. Food 
intolerances can be either of an enzymatic nature (e.g. lactose intolerance) or of 
pharmacological origin. Food allergies are either IgE mediated or non-IgE mediated. 
The most common IgE mediated food allergies are directed against proteins from 
cow’s milk and hen’s egg, especially in children [5]. Other prominent sources of 
allergens are fish, legumes, meats and grains [5]. Fortunately, 85% of affected 
children outgrow their allergies [6].  
 
Two forms of IgE mediated food allergies have to be distinguished. In class I food 
allergy the sensitisation process occurs in the gastrointestinal tract due to the 
resistance to gastric digestion of these allergens [7]. This kind of food allergy 
dominates in infants. 
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Class II food allergies mainly occur in adults and develop as a consequence of an 
allergic sensitisation to inhalant allergens, such as birch pollen. The immunological 
basis is IgE cross reactivity, which might be clinically relevant or irrelevant [8].  
 
2.2 Symptoms 
Foods may induce a variety of symptoms in allergic persons, and, notably some 
symptoms may equally have an allergic  or a non allergic cause. There may be a 
clear temporal relationship between the intake of the food and the development of 
the allergic symptoms, but symptoms may also develop after hours making the 
relation with the ingested food less clear [5]. 
Organs affected (organ systems) by an allergic reaction are the skin, the eyes, the 
respiratory tract, the gastrointestinal tract and the circulatory system (tab.2). 
Surprisingly the skin is the most affected organ, followed by the eyes and respiratory 
tract, the gastrointestinal tract and the circulatory system are the least affected organ 
system. 
2.2.1 Oral allergy syndrome (OAS) & skin 
The most frequent complex of symptoms of food allergy in adults is the OAS. It 
involves IgE- mediated contact urticaria of lips, oral mucosa, and pharynx [9,10].  
In most cases, the clinical course is mild with symptoms limited to the oropharynx 
and resolving within minutes. In some cases the reaction is more severe, leading 
towards a generalized anaphylactic reaction [9]. The classical OAS is associated with 
sensitization towards heat/pepsin labile plant proteins in patients with pollen-related 
food allergy. In this case, crossreacitivity between homologous plant-derived proteins 
in pollen and vegetable foods is the basis of OAS. About 75% of birch pollen allergic 
patients may experience OAS after ingestion of raw fruits like apples, nuts, carrot, 
celery and kiwi [11]. In this case allergens responsible for OAS are  Bet v 1 
homologues, the major birch pollen allergen. Also, patients sensitised to profilin 
experience OAS. In these subjects tomato, orange and melon are additional 
offending foods [12]. 
The skin is frequently involved in IgE mediated food allergy [5]. Cutaneous symptoms 
may vary from pruritus, urticaria, and angioedema to mobilliform rashes. Acute 
urticaria is the most common skin disorder in adult patients with food allergy [14]. 
Urticaria appears within minutes of ingesting the offending food and may last for 
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several hours [5]. Atopic dermatitis (AD) is a chronically relapsing inflammatory skin 
disease commonly associated with the presence of IgE specific for airborne and/or 
food allergens. AD is commonly associated with food allergy in children but rarely in 
adults [5]. 
 
SKIN (44.7%)  EYES&RESPIRATORY TRACT (23.7%)  
GASTROINTESTINAL 
TRACT (21.7%)  
CIRCULATORY 
SYSTEM (9.9%)  
Urticaria  Rhinoconjunctivitis  Nausea  Anaphylaxis  
Eczema  Larynx edema  Vomiting  
 
Oral allergy 
syndrome  Asthma  Diarrhoea   
Tab. 2: Symptoms in food allergy [13] 
2.2.2 Respiratory disorders 
Respiratory symptoms such as rhinoconjuctivitis and bronchospasm occur in food 
allergic patients following the ingestion of the offending food in association with 
gastrointestinal and skin disorders, but are rarely present as the only symptom [14]. 
Respiratory symptoms elicited by inhalative allergens usually occur without affecting 
other organ systems [5]. 
2.2.3 Gastrointestinal disorders 
Symptoms which fall into this category are nausea, vomiting, gastric retention, 
intestinal hypermotility, abdominal pain and diarrhoea [14]. Reactions develop within 
minutes or several hours after the ingestion of the offending food. Allergens causing 
this kind of symptoms are heat- and pepsin stable and therefore able to reach the 
gastrointestinal tract as intact proteins. 
2.2.4 Anaphylaxis 
Anaphylaxis is defined as a severe, life-threatening, generalized or systemic 
hypersensitivity reaction [5].  It is the most dramatic allergic reaction and always 
requires emergency treatment [5]. Anaphylaxis is caused by the abrupt and massive 
release of mediators from mast cells (basophils) throughout the body. The 
gastrointestinal tract, the skin, the respiratory tract and the cardiovascular system are 
affected. Patients react within minutes after the ingestion of the offending food. The 
reactions can be fatal, if not treated properly.   
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2.3 Food allergens  
2.3.1 Protein families 
The majority of plant food allergens originates from few protein families (fig.2). The 
most prominent are the prolamin- and cupin superfamilies, profilins and Bet v 1 
related proteins. Proteins are part of the same family, if their sequence identity is 
≥30% and/or if there are functional or structural similarities [8]. 
 
 
Fig. 2: The four most prominent protein families of plant food allergens  
(AllFam Database: http://www.meduniwien.ac.at/allergens/allfam/) 
 
Both, the prolamin- and the cupin superfamiliy contain allergens found in nuts (e.g. 
peanut, cashew nut) and seeds (e.g. yellow mustard seed, sesame seeds) [8].  
Profilin is found in every higher organism [12], this protein elicits usually mild 
symptoms like oral allergy syndrome (OAS). Profilin sequences are highly conserved 
among plants, with 70% to 85% identical amino acid residues in sequences of 
different species [8].  
Bet v 1 (Betula verrucosa) related proteins, which cause allergic symptoms are found 
mostly in the pathogenesis related family 10 (PR-10). Expression of these proteins is 
induced by stress (e.g. pathogen infection or physical stress) [8].  
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2.3.2 Profilin 
Profilins are monomeric proteins with a molecular weight between 12 and 15 kDa, 
which are found in all eukaryotic cells (tab.3). 
Profilin was first described in 1977 [15] as an actin binding protein, which sequesters 
actin monomers and inhibit actin filament growth in vitro. Profilin’s function also 
includes remodelling the actin cytoskeleton, regulating actin microfilament assembly 
and dynamics along with other proteins like ADF or fimbrin [16].   
Suppression of profilin gene expression affects cell growth, morphogenesis, and 
seedling growth, highlighting the important physiological role of profilin mediated actin 
dynamics [17, 18]. 
Profilin also plays a role in signal transduction. In any signal-cytoskeleton response 
system, the final signalling targets are most likely proteins, associated to the 
cytoskeleton, which control organization and dynamics [19].  
Profilin’s relevance in allergy was discovered in 1991, when a highly cross reactive  
minor birch pollen allergen, Bet v 2 (Betula verrucosa), was identified as profilin [20]. 
Since then, numerous allergenic profilins were described from pollen, fruits, 
vegetables, spices, seeds, nuts, and latex [21, 22].   
Allergic patients whose sera contain profilin-specific IgE commonly show allergic 
symptoms towards a large number of unrelated plants. However, positive in vitro 
testing, only gives information about the state of sensitisation, not about the (clinical) 
relevance of the tested allergen. 
Despite extensive cross reactivity among plant profilin and to the human homologue 
as well, it seems that a large proportion of IgE reactivities to profilins is clinically 
irrelevant [23, 24]. However, a major role (clinical relevance) for profilin in plant food 
allergy has been determined for melon (Cucumis melo) [25] orange (Citrus sinensis) 
[26], tomato (Solanum lycopersicum), and banana (Musa paradisiaca) [27]. 
Allergen name Source Trivial name 
Ana c 1 Ananas comosus Ananas 
Api g 4 Apium graveolens Celery 
Cit s 2  Citrus sinensis Sweet orange 
Dau c 1 Daucus carota Carot 
Sol l 1 Solanum lycopersicum Tomato 
Mus xp 1 Musa x paradisiaca  Banana 
Tri a 12 Triticum aestivum Wheat 
Tab. 3: Examples of profilins, which play a role in food allergy (IUIS Database: 
http://www.allergen.org/Allergen.aspx) 
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2.3.3 Cross reactivity 
Cross reactions are described as the recognition of epitopes present on an allergen 
by specific IgE of another allergen (homologous proteins). This is caused by highly 
conserved 3D structures and/or amino acid sequences of allergens, which result in 
highly similar epitopes (e.g. among different profilins or within Bet v 1 protein family). 
Allergen specific IgE antibodies are therefore not able to distinguish between these 
different antigens [28, 29]. So far, several pollen-food allergy syndromes have been 
described, such as birch-fruit [8,30], celery-mugwort-spice [31], latex-fruit [32, 33], 
mugwort-mustard [34], mugwort-peach [35], and ragweed-melon-banana syndrome 
[36], and the pan-allergens profilin [24, 37] and lipid transfer proteins (LTPs) [38]. The 
prerequisite for allergenic cross reactivity with clinical significance is a sequence 
identity of at least 50% [39]. 
 
3. Wheat  
3.1 The history of wheat 
Wheat has accompanied humans since remote times (as far back as 3000 to 4000 
BC) in their evolution and development, evolving itself from wild grasses to its 
primitive form (emmer wheat) and from there, with human help, into the presently 
cultivated species. The more important modern wheat species are hexaploid bread 
wheat (Triticum aestivum) and tetraploid durum wheat (Triticum turgidum L. Var. 
durum), which are different from one another in genomic make-up, in grain 
composition and in food end-use quality attributes. Except for the very warm tropics, 
wheat adapts to all diverse climatic conditions prevailing in agricultural lands and, 
therefore, it is harvested in the world all year round. Its wide adaption to diverse 
environmental conditions, along with its unique characteristic of possessing a 
viscoelastic storage protein complex called gluten, are the main factors making wheat 
the most important food crop in the world [40]. 
Despite the many benefits humans draw from wheat, there are a few significant 
downsides to wheat consumption. Wheat can cause diseases like celiac disease, 
wheat allergy, bakers’ asthma, and wheat dependant exercise induced anaphylaxis 
(tab.4). 
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3.2 Wheat related diseases 
There are three major diseases caused by wheat consumption or wheat flour 
inhalation (tab.4). A fourth disease is the very rare wheat-dependant exercise 
induced anaphylaxis (WDEIA).  
Wheat related 
diseases  
Antibody/ 
Exposure route  Prevalence  Symptoms  
Celiac disease  IgA/ingestion  1% in Europe  
diarrhoea,  
steatorrhoea 
weight loss, 
fatigue, anaemia  
Wheat allergy  IgE/ingestion  4% sensitization in 3 y 
old children [41]   
urticaria, eczema,  
dermatitis,  
Bakers‘ asthma  IgE/inhalation  15% of bakers, 
millers,...  Asthma, rhinits 
WDEIA IgE/Ingestion unknown anaphylaxis 
Tab. 4: characterisation of wheat related diseases 
3.2.1 Wheat allergens 
So far 6 allergens are listed in the IUIS allergen database (tab.5). 
 
Tri a 12 (Triticum aestivum) belongs to the profilin family. Profilins are monomeric 
proteins with a molecular weight between 12 and 15 kDa, which are found in all 
eukaryotic cells. 
 
Tri a 14 is part of a group of proteins called nonspecific lipid transfer proteins (LTPs). 
Its molecular weight is 9 kDa and LTPs were identified as relevant allergens in plant 
foods, mainly Rosaceae fruits, and pollens, being particulary important in the 
Mediterranean area. It was reported that wheat LTP plays a major role in bakers’ 
asthma, an occupational disease affecting up to 15% of bakers and other cereal flour 
handling professions [42]. 
 
Tri a 18 is an IgE-binding protein consisting of four hevein-like domains. Wheat germ 
agglutinin (Tri a 18) was identified as an allergen relevant in bakers’ asthma [43]. 
 
Tri a 19 plays a major role in wheat-dependant, exercise-induced anaphylaxis [44]. 
Omega-5 gliadin‘s molecular weight is 65 kDa. 
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Tri a 25, wheat thioredoxin is considered to be responsible for symptoms in bakers’ 
asthma. It is suspected to cross react with thioredoxins from maize and grass pollen 
[45]. 
  
Tri a 26, Gluten is the protein component of wheat flour. HMW glutenin from wheat 
was described as a major allergen in wheat-dependant exercise-induced 
anaphylaxis. Also, gluten is the causative agent of celiac disease [46]. 
 
Name  Function  Disease  Tissue  
Profilin 
Tri a 12  actin binding protein  
Bakers‘ asthma  
Wheat allergy seed & pollen  
LTP 
Tri a 14 lipid transfer protein 
Bakers’ asthma 
 
seed  
Hevein like protein 
Tri a 18  agglutinin  Bakers‘ asthma seed  
Omega-5-Gliadin  
Tri a 19  seed storage protein  WDEIA  seed  
Thioredoxin 
Tri a 25  
protein disulfid 
reductase  Bakers‘ asthma  seed  
Glutenin Subunit, 
Tri a 26  seed storage protein  
Celiac disease 
WDEIA seed  
Tab.5: Wheat allergens listed in the IUIS Database  (http://www.allergen.org/Allergen.aspx) 
3.2.2 Celiac disease 
The most prominent wheat related disease is celiac disease (CD). CD represents an 
enteropathy, which is caused by ingestion of wheat proteins in genetically 
predisposed individuals [47, 48]. CD patients exhibit IgA antibody and T cell reactivity 
mainly against a complex fraction of alcohol soluble proteins in wheat seeds, termed 
gliadins (table 5) [49], and develop autoreactive IgA antibodies against the 
endomysial autoantigen tissue transglutaminase and reticulin [46, 50, 51]. Around 
1% of the European population suffer from CD, the symptoms include (bloody) 
diarrhoea, weight loss and anaemia. The only therapy available is to avoid wheat 
containing foods altogether. 
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3.2.3 Wheat food allergy 
IgE mediated food allergy, another genetically determined hypersensitivity of the gut, 
can also be caused by dietary intake of wheat proteins [52, 53].  As in other IgE- 
mediated food allergies, symptoms of wheat allergy become apparent within 30 
minutes after ingestion of the culprit food with cutaneous, respiratory and 
gastrointestinal manifestations, which can lead to anaphylaxis [54]. These reactions 
are clinically distinct from other adverse reactions to wheat proteins, including bakers’ 
asthma, celiac disease and WDEIA [55, 56, 57]. Although there are some similarities, 
differences are present in wheat specific allergens, patterns of exposure, 
immunologic mechanism and pathophysiology [58].The only available therapy so far 
is avoidance of the allergen source. 
3.2.4 Bakers’ Asthma 
Bakers’ asthma is one of the most common forms of occupational asthma, affecting 
up to 15% of bakers, millers, and pastry factory workers [59, 60]. The disorder is 
mainly caused by an IgE mediated allergic response to inhalation of cereal flours. 
The major causative allergens of the bakers’ asthma condition are proteins derived 
from wheat and rye flours, although baking additives, such as fungal α-amylase, are 
also important [59, 61]. Symptoms are, as the name indicates, asthma, but also 
rhinitis. So far no therapy but avoidance of the allergen source is available. 
3.2.5 Wheat dependant exercise induced anaphylaxis (WDEIA) 
Wheat dependant exercise induced anaphylaxis is a severe IgE mediated allergic 
reaction provoked by the combination of wheat ingestion with intensive physical 
exercise over the following hours [62]. WDEIA is a distinct form of wheat allergy, 
which is elicited by allergens different from wheat allergy or bakers’ asthma. 
Symptoms include generalized urticaria, hypotension and shock [62]. 
4. Allergy diagnosis 
4.1 Current diagnostic tools 
4.1.1 In vivo tests 
Skin prick tests (SPT) are used to screen for food specific IgE [63]. SPT are easily 
performed and show results within 15 minutes. The diagnostic accuracy depends on 
the quality of allergen extracts used. For many foods, commercial extracts for SPT 
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show a low sensitivity resulting in a high rate of false-negative results. This is caused 
by the low abundance or the lack of stability of several allergens to endogenous 
enzymatic processes taking place in plant food extracts [64].  
4.1.2 Food challenges 
The oral challenge is a diagnostic test, which provides strong evidence of a food 
allergy, and allows the clinician to recommend a correct elimination diet. However, in 
patients with a history of anaphylaxis after the ingestion of an isolated food, 
challenges are not the method of choice [64]. 
Food challenges can be performed open, single blinded, or double blinded. The 
double blind placebo controlled food challenge (DBPCFC) is considered to be the 
gold standard for the diagnosis of food allergy. In this test placebo and allergen are 
administered in a random order. Both, patient and health care professional do not 
know when the placebo or allergen is applied. The problem with DBPCFC is the 
absence of a uniform procedure manual, which makes comparison of studies difficult 
[64]. 
4.2 In vitro tests 
4.2.1 Assays for specific IgE antibodies 
So far the measurement of allergen specific IgE in the blood is the most useful 
marker in clinical diagnostics.  
Typical assays for specific IgE antibodies are CAP/RAST, ELISA and EAST and 
RAST [5, 65].  
An antibody assay will generally not be able to discriminate between genuine 
sensitization and serological cross reaction to a given structure [5]. 
4.3 Recombinant allergens 
Improving diagnostic tests for food allergy with recombinant manufactured allergens 
is vital for an accurate diagnosis in patients suffering from food related symptoms. 
Most allergens involved in food allergy are plant-derived proteins, which are easily 
degraded by physical and/or chemical strain during the extraction process. This does 
not only result in difficulties during the preparation of food extracts but also implies 
that certain allergens within an extract may be degraded during the storage for longer 
time periods [66]. 
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Examples for successfully produced allergens are:  
Recombinant Api g 1: the major allergen from celery, was used for skin tests. The 
results indicated that this protein allowed accurate in vivo diagnosis of celery allergy 
in areas where birch trees are common [67]. 
Recombinant Cor a 1.0401: Sera of patients with an allergy to hazelnut were 
investigated either with the recombinant allergen or with hazelnut extract. EAST with 
recombinant Cor a 1 yielded a sensitivity of 95% compared to 70% of the 
commercially available CAP/RAST system, which is based on a total food extract 
[68]. 
5. Aim of the study 
The aim of this study was to clone the cDNA sequence of Tri a 12, the Bet v 2 
homologue from wheat (Triticum aestivum), to express it as a non-fusion protein in E. 
coli, and to purify it to near homogeneity. 
Recombinant Tri a 12 was characterised regarding its molecular and immunological 
features. Furthermore, as this study is a part of the EC-funded project 
EUROPREVALL (“The Prevalence, Cost and Basis of Food Allergy across Europe”), 
rTri a 12 will be used for CAP establishment (Phadia, Uppsala, Sweden), CHIP 
production (VBC Genomics, Vienna, Austria), and histamine release assays (RefLab, 
Copenhagen, Denmark). With the establishment of novel component-resolved 
diagnostics epidemiologic studies across Europe will be undertaken within this 
project. 
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II. MATERIALS & METHODS 
1. Cloning 
1.1 Overview 
 
 
 
 
Fig.3: Cloning Overview 
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1.2 Buffers & Solutions 
DEPC/MilliQ H2O 
500 µl DEPC per litre MilliQ-H2O, incubate in lamina flow overnight 
 
10x FA gel buffer (RNA)   1x FA gel running buffer 
200 mM MOPS    100 ml 10x FA gel buffer 
50 mM sodium acetate   20 ml 37% formaldehyde 
10 mM EDTA    880 ml DEPC/MilliQ-H2O 
pH to 7.0 with NaOH 
 
5x TBE gel running buffer 
445 mM TRIS pure  
445 mM  boric acid  
10 mM  EDTA-Na2 
 
SOC medium     LB medium  
0.5%  yeast extract    0.5% yeast extract 
2.0%  peptone     1% peptone 
10 mM  NaCl     1% NaCl 
2.5 mM KCl     
10 mM MgCl2     LB agar 
20 mM MgSO4 
    
LB medium 
20 mM  glucose     15 g agar/l 
 
1.3 Plant material 
Triticum aestivum cv.Edison was chosen, because of its widespread use in 
Lower Austria [RWA Raiffeisen Ware Austria AG; Vienna, Austria]. 
 
Material: 
• T. aestivum cv. Edison corn 
• Petri dish 
• MilliQ water 
• Sterile scalpel 
• Liquid nitrogen 
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Protocol: 
Ten grams of wheat corn were incubated in a Petri dish (filled with water) for 48 
hours. After two days the wheat sprouts were harvested by separation from the 
corn (with a sterile scalpel) before they were frozen in liquid nitrogen. 
 
1.4 RNA isolation 
To obtain stable RNA a ribonuclease free environment was provided. All lab 
equipment was heat sterilzed. All solutions were treated with DEPC to inactivate 
ribonucleases (by binding histidine residues). 
 
Material: 
• Wheat sprouts (2 days old) 
• Liquid nitrogen 
• Mortar and pestle 
• Spectrum Plant Total RNA Kit (Sigma Aldrich, St. Louis, MO, USA) 
• β−mercaptoethanol 
 
Protocol: 
All centrifugation steps were carried out at 16,100 g.  
Wheat (T. aestivum) samples were collected after 2 days. Wheat sprouts (2 d 
old, 110 mg) were shock frozen in liquid nitrogen and ground to a fine powder 
using pre-chilled mortar and pestle. Five micro litres β−mercaptoethanol were 
added to 500 µl lysis solution. Then this mixture was added to 110 mg ground 
sprout material. This mixture was transferred to an Eppendorf tube. After one 
minute of thorough vortexing, the sample was incubated at 56°C for 5 minutes. 
To separate cellular debris, the sample was centrifuged for 3 minutes. The 
resulting supernatant was pipetted into a filtration column (seated in a 2 ml 
tube), and centrifuged for one minute. Afterwards, 250 µl binding solution were 
added to the flow through. After mixing gently, the sample was transferred onto 
the binding column (seated in a 2 ml collection tube) and spun for 1 minute. The 
flow through was discarded. 
Washing the sample included three steps: 500 µl wash solution I were 
transferred into the column. After 1 minute of centrifugation and discarding of 
the flow through, 500 µl wash solution II were added and the column was 
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centrifuged for 30 seconds. The flow through was discarded. Wash solution two 
was applied twice (same procedure). To dry the column, it was spun for 1 
minute. Elution was executed in a new (sterile) 2 ml collection tube. Fifty micro 
litres elution solution was pipetted directly onto the centre of the binding matrix. 
After incubation for 1 minute at RT, the column was spun for 1 minute. The flow 
through was stored at -20°C. 
1.5 RNA Quality Control 
1.5.1 Photometry 
Photometric control of the isolated RNA was performed to assess its quality.  
 
Material: 
• HELLMA precision cell (made of Quartz SUPRASILR; Light path 10 mm; 
Centre 10 mm; Type Nr. 105.202-QS) 
• DEPC/MilliQ-H2O 
• Wheat (T. aestivum) total RNA  
• HITACHI U-1800 Spectrophotometer (Tokyo, Japan) 
 
Protocol: 
RNA concentration was determined spectrophotometrically by a wavelength 
scan from 200 nm to 300 nm. Pure preparations of RNA usually have an 
OD260nm/280nm ratio of 2[69]. Samples were diluted in DEPC water 1 : 40 (test 
volume 100 µl). 
For calculating the RNA yield the following formula was used: 
   
OD260nm x dilution factor x 40 = µg/ml [69] 
 
1.5.2 RNA agarose gel electrophoresis 
During agarose gel electrophoresis RNA (or DNA) is separated and visualized. 
An electric current is applied to the agarose gel, which leads to the migration of 
negatively charged RNA (DNA) molecules according to their size. Ethidium 
bromide is added to the agarose gel to visualize the RNA (DNA). This dye 
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intercalates the RNA (DNA) and by irradiating the agarose gel with ultra violet 
light the RNA (DNA) becomes visible. 
 
Material: 
• Agarose 
• 10x FA gel buffer 
• DEPC/MilliQ water  
• 37% formaldehyde 
• Ethidium bromide (10 mg/ml) 
• RiboRuler RNA ladder, low range (fig.4;Fermentas; 
St. Leon-Roth, Germany )  
• Total RNA extract 
• Loading dye solution for RNA electrophoresis 
(Fermentas; St. Leon-Roth, Germany) 
• 1x  FA running buffer 
 
Protocol: 
The gel was prepared by mixing 1.2 g agarose, 10 ml 10x FA gel buffer and 
DEPC-MilliQ water (total volume: 100 ml). This mixture was heated in a 
microwave oven and after cool down to 65°C, 1.8 ml 37% formaldehyde and 
1µl ethidium bromide were added. The solution was poured onto the 
gel support and solidification was finished, the gel was equilibrated for 30  
minutes in 1x FA buffer. Total RNA extract (5 µl) was mixed with 2x loading dye 
solution (5 µl) and incubated at 65°C for 5 minutes . After the gel was 
transferred to the gel chamber, 10 µl sample and 3 µl RNA marker were 
loaded (running conditions: 65 V/35.5 mA).  
1.6 Complementary DNA first strand synthesis (RT-PCR) 
Reverse transcriptase PCR is a form of PCR using a RNA dependant DNA 
polymerase to transcribe mRNA to cDNA.  
 
 
 
Fig. 4: RNA marker 
(Copyright: 
www.fermentas.com) 
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Material: 
• T25NN (oligodT) for cDNA synthesis: 
5’ – GGAGAAGGATTTTTTTTTTTTTTTTTTTTTTTTT – 3’; 100pmol/µl 
• total RNA (607 mg/ml)  
• DEPC water     
• 5x buffer for M-MuLV Reverse Transcriptase  
• RiboLock ribonuclease inhibitor (40 U/µl) 
• dNTPmix (10 mM each) 
• M-MuLV reverse transcriptase (20 U/µl) 
 
Reaction was carried out in a Primus 96plus thermal cycler (MWG Biotech; High 
Point, NC, USA) 
 
RiboLock ribonuclease Inhibitor, 5x buffer for M-MuLV RT and M-MuLV reverse 
transcriptase were purchased from Fermentas (St. Leon-Roth, Germany) 
 
Protocol: 
Reaction mix (20µl total reaction volume): 
• 7 µl DEPC water 
• 3 µl total RNA 
• 1 µl T25NN 
Reaction mix was incubated at 70°C for 5 minutes in  a thermal cycler. After 
denaturing the following reagents were added: 
• 4 µl 5x buffer for M-MuLV reverse transcriptase  
• 1 µl Ribolock ribonuclease inhibitor  
• 2 µl dNTPmix  
After incubation at 37°C (thermal cycler) for 5 min utes 
• 2 µl M-MuLV reverse transcriptase were added 
  
Finally, the complete reaction mix was incubated at 37°C (thermal cycler) for 60 
minutes. The reaction was terminated by an incubation at 70°C for 10 minutes. 
cDNA was stored at -20°C. 
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1.7 PCR 
The polymerase chain reaction is a method for amplifying DNA in vitro. It uses 
the heat stable DNA polymerase from Thermus aquaticus. High temperature is 
used to denature the template DNA into two single stranded molecules. Two 
small oligonucleotides are used as primers. These small molecules anneal to 
their respective strands. Following primer annealing, primer extension results in 
a copy of the original DNA template. This cycle can be repeated as often as 
desired, but usually thirty cycles suffice.  
1.7.1 Primer Design 
To design appropriate primers, sequences from the genbank database were 
retrieved. Triticum aestivum ribulose-1,5-bisphosphate carboxylase/oxygenase 
large subunit (rbcl) was chosen as a housekeeping gene to check the integrity 
of the total RNA extracted (see chapter 1.4). Housekeeping genes are 
constitutively expressed genes, which give information about the quality of the 
template (c)DNA.  
 
DNA – Sequences 
1.) Triticum aestivum profilin isoform 3 
Genbank Database accession number: X89827 
>gi|1008444:51-473 T.aestivum mRNA for profilin (clone TaPRO3) 
 
forward primer: 5’ – ATGTCGTGGAAGGCGTACGTCGA – 3’ (rTri a 12 IF3 for) 
reverse primer: 5’ – AGTAACCCTGATCGATCAGGTAATC – 3’ (rTri a 12 IF3 
rev) 
 
2.) Triticum aestivum ribulose-1,5-bisphosphate carboxylase/oxygenase large 
subunit (rbcl) 
Genbank Database accession number: AY328025 
>gi|32966579:60-1493 Triticum aestivum ribulose-1,5-bisphosphate 
carboxylase/oxygenase large subunit (rbcl) mRNA, complete cds; chloroplast 
gene for chloroplast product 
 
forward primer : 5’ – TGGGGTTCCGCCCGAAGAAGCA – 3’ 
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reverse primer : 5’ – ACTTGGATACCATGAGGCGGGCCT – 3’ 
 
All primers were purchased from MWG BIOTECH (High Point, NC, USA). 
Primers were diluted in MilliQ water to a working concentration of 5 pmol/µl. 
1.7.2 PCR reaction  
 
Material: 
• MilliQ water 
• Wheat cDNA 
• Primers (5 pmol/µl) 
• 25 mM MgCl2 
• 10 mM dNTPmix 
• Taq polymerase buffer  
• Taq polymerase (5 U/µl) 
Taq polymerase (buffer), dNTP mix and MgCl2  were purchased from Fermentas 
(St. Leon-Roth, Germany). 
Reaction was carried out in a Primus 96plus thermal cycler (MWG Biotech, High 
Point, NC, USA). 
 
Protocol: 
PCR reaction mix (50 µl total reaction volume) 
• 22.5 µl  MilliQ-H2O 
• 5 µl   Taq polymerase buffer  
• 5 µl  cDNA 
• 5 µl  Primer forward (rTri a 12 IF3 for) 
• 5 µl  Primer reverse (rTri a 12 IF3 rev) 
• 4 µl  MgCl2  
• 3 µl  dNTPmix 
• 0.5 µl  Taq polymerase  
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1.7.3 PCR program: 
• 95°C  3’ 
 
• 95°C  1’  
• 60°C (T A) 1’       35 x 
• 72°C (T X) 2’ 
 
• 72°C  10’ 
• 4°C  ∞ 
 
Tx extension temperature 
TA annealing temperature 
1.8 Agarose gel electrophoresis  
To determine the success of the PCR experiment, an agarose gel 
electrophoresis was performed (for method background see chapter 1.5.2). 
Material: 
• 2.4 g agarose  
• 200 ml 1xTBE Buffer 
• 30 µl Ethidium bromide (10 mg/ml) 
• 5 µl DNA Marker (fig.5; 100 bp ladder plus) 
• 6x Loading Dye solution  
• 20 µl PCR product  
DNA Marker (100 bp ladder plus) and 6x Loading 
Dye solution were purchased from Fermentas (St. 
Leon-Roth, Germany) 
 
Protocol: 
Agarose and TBE buffer were mixed and heated in a  
microwave oven. Before the gel was poured, 30 µl  
Ethidium bromide were added. After the gel 
hardened, the gel chamber was filled with 1x TBE  
running buffer. After 10µl sample were mixed with 
Fig. 5: DNA marker (Copyright: 
www.fermentas.com) 
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2µl 6x loading dye, the gel was transferred to the gel chamber. 
Running conditions: 130 V/60 mA 
1.9 Gel extraction 
QIAEX II gel extraction kit is designed to extract and purify DNA from any 
agarose gel without phenol extraction or ethanol precipitation. DNA molecules 
are adsorbed to QIAEX II silica particles in the presence of high salt. All non-
nucleic acid impurities such as agarose, proteins, salts, and ethidium bromide 
are removed during washing steps. The pure DNA is eluted with 20 µl water. 
1.9.1 QIAGEN QIAEX II – Gel Extraction Kit 
Material: 
• Agarose gel 
• Sterile scalpel 
• Gel extraction kit (Qiagen; Hilden, Germany) 
 
Protocol: 
The DNA band of interest was excised from the agarose gel with a sterile 
scalpel. After weighing the fragment, 3 volumes of Buffer QX1 were added. 
After resuspending the QIAEX II particles, 30 µl were added to the DNA/QX 1 
mixture. To solubilise the agarose and bind the QIAEX II particles to the DNA, 
the reaction mix was incubated at 50°C for 10 minut es. 
The procedure was continued with a centrifugation at 16,100 g for 30 seconds. 
The pellet was washed with 500 µl QX 1 and centrifuged again (see above). 
The supernatant was removed and the pellet washed twice with buffer PE to 
remove remaining salt contaminations. Following the last washing step, the 
supernatant was discarded and the pellet dried until it turned white (40 
minutes). 
To obtain the DNA, 20 µl of aqua ad injectabilia were added to the dry pellet. 
After resuspension and incubation (5’ RT) a last centrifugation step followed 
(16,100 g). The DNA containing supernatant was transferred to a new 1.5 ml 
tube. 
MATERIALS and METHODS 
31 
 
1.9.2 PCR of gel extraction products (Gelex PCR) 
To obtain more PCR product, a new PCR experiment with the extracted DNA 
was performed. The same conditions as in the first PCR experiment (chapter 
1.7) were employed, except for a 1°C higher anneali ng temperature (61°C), and 
instead of 5 µl cDNA,1 µl DNA from the gel extraction was used. 
1.9.3 Agarose gel electrophoresis of Gelex PCR 
The same conditions as in the agarose gel electrophoresis of the PCR product 
(chapter 1.8) were used. After excising the correct band from the agarose gel, a 
gel extraction procedure (chapter 1.9.1) yielded a sufficient amount of DNA, 
encoding profilin. 
1.10 Cloning: ligation & transformation 
To shuttle the purified PCR product to E. 
coli cells it has to be combined with a 
suitable plasmid vector (pCR2.1-TOPO, 
Invitrogen; Carlsbad, CA, USA). This 
linearized vector contains single 3´-
thymidine overhangs (fig.6), whereas the 3´ 
ends of the PCR product are made of 
single deoxyadenosine overhangs. This 
allows PCR inserts to ligate with the vector. 
Topoisomerase I from Vaccinia virus binds 
to duplex DNA at specific sites and cleaves 
the phosphodiester backbone after 5′-
CCCTT in one strand [70]. The energy 
from the broken phosphodiester 
backbone is conserved by formation of 
a covalent bond between the 3′ 
phosphate of the cleaved strand and a 
tyrosyl residue (Tyr-274) of 
topoisomerase I. The phospho-tyrosyl 
bond between the DNA and enzyme 
can subsequently be attacked by the 5′ 
Fig.6: function of topoisomerase (Copyright: 
Invitrogen, Carlsbad, CA, USA) 
Fig.7: cloning vector (Copyright: Invitrogen, 
Carlsbad, CA, USA) 
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hydroxyl of the original cleaved strand, reversing the reaction and releasing 
topoisomerase [71].  
The vector contains part of the lacZ Operon. This allows for a blue/white colony 
selection after the transformation.  
1.10.1 Ligation 
Material: 
• PCR product 
• Salt solution, 1.2 M NaCl + 0.06 M MgCl2 
• pCR2.1 vector (fig.7; Invitrogen; Carlsbad, Ca, USA) 
 
Reactions were carried out in a Primus 96plus thermal cycler (MWG-Biotech, 
High Point, NC, USA ). 
 
Protocol: 
Four micro litres PCR product were added to 1 µl salt solution and 1 µl pCR2.1 
vector. After 15 minutes of incubation at 22°C, the  ligation was completed. 
 
1.10.2 Transformation 
Material: 
• Ligation product (PCR product/pCR2.1 vector) 
• TOP10 chemically competent E. coli cells (Invitrogen; Carlsbad, Ca, 
USA) 
• SOC medium 
• LB medium 
• Ampicillin (100mg/ml) 
• XGal (20mg/ml) 
 
Protocol: 
Three micro litres ligation product were added to 50 µl of One Shot TOP10 
chemically competent E. coli cells. After 15 minutes on ice and 30 seconds on 
42°C, 250 µl SOC medium were added. Samples were in cubated at 37°C for 1 
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hour. Petri dishes were prepared with 40 µl ampicillin and 80 µl XGal enriched 
LB agar medium. 
The transformed bacteria were centrifuged at 16,100 g for 30 seconds. One 
hundred and fifty micro litres of the supernatant were discarded. After the pellet 
was resupended, 100 µl bacterial culture were plated on one Petri dish (LB-amp 
agar), on another 50 µl, and as a negative control 100 µl bacterial culture 
containing an empty vector on a third plate. The Petri dishes were incubated at 
37°C over night. 
 
1.11 Colony screening 
Material: 
• Autoclaved toothpicks 
• Bacterial colonies 
• LB medium 
• Ampicillin (100 mg/ml) 
• Streptromycin (20 mg/ml) 
 
Protocol: 
Autoclaved toothpicks were used to transfer white colonies (LacZ operon 
destroyed by insert) to bacterial tubes, filled with 4 ml LB medium, 4 µl ampicillin 
(100 mg/ml), and 4 µl streptomycin (20 mg/ml). The rationale was, that the 
vector contained the LacZ operon, which would colour the colonies blue, if the 
transformation was unsuccessfull. The vector also holds an ampicillin resistance 
(serves as a selection marker). The bacterial strain TOP10 contains a 
streptomycin resistance. So it can be ensured, that only nonblue, streptomycinr, 
ampicillinr bacteria grow in culture tubes containing LB with ampicillin and 
streptomycin. 
1.12 Plasmid DNA preparation 
After the resuspended (buffer A1) bacteria were treated with SDS/alkaline lysis 
buffer (A2) the plasmid was liberated. Buffer A3 neutralizes the lysate and 
allows the binding of plasmid DNA to the silica membrane of the purification 
column. Salts, metabolites, and other contaminations are removed by washing 
with buffer A4. Pure plasmid DNA is eluted with slightly alkaline buffer AE. 
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Material:  
• Nucleospin Plasmid kit (Macherey-Nagel, Düren, Germany) 
• Bacterial culture (containing plasmid) 
 
Protocol: 
All centrifugation steps were carried out at 11,000 g. 
Escherichia coli TOP10 LB culture (4x1 ml) was transferred in a 1,5 ml tube and 
centrifuged for 30 seconds. The supernatant was discarded. The pellet was 
resuspended in 250 µl of Buffer A1. To facilitate cell lysis, 250 µl buffer A2 were 
added. After the tube was inverted 8 times, incubated for five minutes at RT, 
300 µl buffer A3 were added and the solutions mixed by inverting the tubes. 
To clarify the lysate, it was centrifuged for 10 minutes. A separation column was 
placed in a 2 ml collecting tube and the supernatant of the previous step was 
loaded. After centrifugation for 1 minute the DNA bound to the column. The flow 
through was discarded. 
After 600 µl of buffer A4 (washing buffer) were added to the column, it was 
centrifuged for 1 minute. The flow through was discarded. After drying the silica 
membrane (in the column) by centrifuging for 2 minutes, the DNA was eluted. 
The column was transferred to a new 1.5 ml tube and 50 µl of buffer AE (elution 
buffer) were added. After incubation for 1 minute at room temperature and a 
centrifugation for 1 minute, the elution step was completed. 
 
1.13 EcoRI Digestion 
Purified plasmid DNA (pCR2.1-TOPO+wheat profilin insert) was digested with 
the restriction enzyme EcoRI, prior to DNA sequencing. Restriction enzymes cut 
double stranded DNA at unique positions (restriction sites). This results in DNA 
molecules with either blunt- or sticky ends. If both vector and insert, are cut with 
the same restriction enzyme(s) it is possible to ligate the two molecules, 
resulting in a new combined DNA molecule. 
The pCR2.1 vector contains EcoRI restriction sites near both ends of the insert 
at positions 284 & 302 (fig.7) 
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Material: 
• MilliQ water 
• 10x fast digest buffer  
• DNA (from plasmid preparation) 
• Fast digest enzyme EcoRI 
 
10x fast digest buffer and fast digest enzyme EcoRI were purchased from 
Fermentas (Hilden, Germany) 
Reaction was carried out in a Primus 96plus thermal cycler (MWG-Biotech, High 
Point, NC, USA). 
 
Protocol: 
Reaction mix (20 µl total reaction volume): 
• 15 µl MilliQ water 
• 2 µl 10x fast digest buffer  
• 2 µl DNA 
• 1 µl fast digest Enzyme EcoRI  
 
After mixing thoroughly, the digestion reaction was performed at 37°C for 15 
minutes. The success of the digestion was confirmed by an agarose gel 
electrophoresis (see chapter 1.8). 
1.14 Sequencing 
To determine the sequence of the cloned gene, DNA sequencing method 
developed by Frederick Sanger was used [72]. This method is based on DNA 
synthesis in the presence of dideoxy nucleotide triphosphates, which differ from 
normal deoxynucleotides in their lack of a 3’ hydroxyl group. During a PCR the 
respective dideoxy nucleotide triphosphates can be incorporated into a growing 
chain, but when incorporated they terminate synthesis due to the lack of a 3’ 
hydroxyl group [73]. 
For every analysis, four reaction tubes are prepared (A, C, G, T). Each tube 
receives a different dideoxynucleotide (ddATP, ddCTP, ddGTP, ddTTP), 
together with the normal deoxynucleotide triphosphates, DNA polymerase, and 
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fluorescence labelled primers. A dideoxy nucleotide triphosphate will be 
incorporated randomly. This results in the synthesis of truncated DNA 
fragments of various lengths. These fragments can be visualized by 
electrophoresis, if a labelled primer (e.g. infra red dye) is used for the PCR 
reactions. 
 
The sequencing procedure is divided into the sequencing-PCR, electrophoresis  
and data analysis. 
1.14.1 Sequencing PCR 
 
Material: 
• SequiTherm EXCEL II Long Read L-C Kit (Epicentre Biotech, Madison, 
WI, USA) 
• DNA template, amount needed was calculated using the following 
formula:  
 
400 fmol x 660 g/Mol x length of insert (bp) = fg insert required for sequencing 
[69] 
 
• Primers:  
T7: IRD-800 (infra red dye) modified:  
5’ – TAATACGACTCACTATAGGG – 3’ 
M13:  
5’ – CAGGAAACAGCTATGACC – 3’ 
   primer concentration: 5 pmol/µl 
 
All reactions are carried out in a Primus 96plus thermal cycler (MWG-
Biotech,High Point, NC, USA) 
 
 
Fig.8: sequence of pCR2.1-TOPO (EcoRI restriction sites bold; T7 primer printed in black, M13 primer 
printed in red ) 
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Protocol: 
Sequencing mix (17 µl total reaction volume) 
• 7.2 µl 3.5xSequiTherm EXCEL II sequencing buffer 
• 3.8 µl deionized water 
• 3 µl DNA template (conc.: 22.8 ng/µl) 
• 2 µl T7 or M13 primer (conc.: 5 pmol) 
• 1 µl SequiTherm EXCEL II DNA polymerase (5 U/µl) 
 
2 µl of each termination mix (ddGTP, ddATP, ddTTP, ddCTP) were pipetted into 
a 0,25 ml PCR tube. To each termination mix 4 µl sequencing mix were added. 
 
PCR program: 
• 95°C 5’ (template denaturation step) 
 
• 95°C 30’’ 
• 50°C 15’’       30x 
• 70°C 1’ 
 
• 4°C ∞ 
 
Afterwards 3 µl stop solution were added. 
1.14.2 Sequencing gel electrophoresis (41 cm gel) 
 
Material: 
• Urea (99,5% p.a.; ROTH, Karlsruhe, Germany) 
• MilliQ water 
• 5xTBE  
• DMSO (100% Dimethyl Sulfoxide; Sigma Aldrich,  St. Louis, MO, USA )  
• Long Ranger gel solution 
• Temed (100%; ROTH, Karlsruhe, Germany) 
• 10% APS 
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Protocol: 
Sequencing gel composition (37.5 ml total volume): 
• 15.75 g Urea (7M)  
• 22.175 ml MilliQ water    
• 7.5 ml 5xTBE     
• 1.125 ml DMSO (Sigma; 100%)   
• 4.5 ml Long Ranger Gel Solution  
• 37.5 µl Temed (ROTH; 100%)   
• 262.5 µl 10% APS    
 
After pouring the sequencing gel and waiting for 1.5 h to allow polymerization, 
the gel was mounted on the DNA-sequencer (DNA Sequencer model 4000L, 
LICOR, Lincoln, NE, USA). One micro litre of sample was loaded into each slot. 
The sequencing procedure was performed overnight. LICOR Base ImagIR Data 
Collection V2.31 software was used for sequence analysis. 
1.14.3 Data analysis 
Data was analyzed with the LICOR Image Analysis V4.0 and the LICOR ALIGN 
IR V2.0 software. 
For analysis on the amino acid level the following software was used: 
 
• EMBOSS Transeq 
• ClustalX 
 
The sequences retrieved from sequencing were analyzed further and compared 
to database entries (DNA & Protein). DNA sequences were translated using the 
EMBOSS TransSeq software. Alignments were done with ClustalX. 
MATERIALS and METHODS 
41 
 
2. Expression 
2.1 Overview 
 
Fig.9: Overview expression 
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2.2 Buffers & Solutions 
SOC medium    LB medium  
0.5%  yeast extract   0.5% yeast extract 
2.0%  peptone    1% peptone 
10 mM  NaCl    1% NaCl 
2.5 mM KCl     
10 mM MgCl2    LB agar 
20 mM MgSO4 
   
LB medium 
20 mM  glucose    15 g Agar/l 
 
SEM buffer     Lysis buffer 
10 mM PIPES    50 mM  NaH2PO4 
15 mM CaCl.2H2O   300 mM NaCl 
250 mM KCl (pH 6.7)   10 mM imidazol 
55 mM  MnCl2.2H2O 
 
2.3 Expression System 
2.3.1 Restriction sites-PCR 
NdeI and EcoRI restriction sites were added to wheat profilin encoding DNA 
using PCR. Subsequently, wheat profilin DNA was ligated into expression 
vector pET17b. The resulting expression plasmid was used to transform 
competent E. coli BL21(DE3). 
Material: 
• Forward primer: 5’ – GGGCATATGTCGTGGAAGGCGTAC – 3’ (rTri a 
12 exp for) 
• Reverse primer: 5’ – CCCGAATTCTTAGTAACCCTGATCGA – 3’ (rTri a 
12 exp rev) 
restriction sites in italics; primer concentration: 5 pmol/l. 
• MilliQ water 
• PCR cocktail (5 µl Taq polymerase buffer + 2 µl 10mM dNTP mix + 3 µl 
25 mM MgCl2 ) 
• Plasmid preparation DNA (clone 3R-pCR2.1) 
• 25 mM MgCl2 
• 10 mM dNTP mix 
• Taq polymerase (5 U/µl) 
MATERIALS and METHODS 
43 
 
• Template DNA (rTri a 12 in pCR2.1) 
 
Taq polymerase (buffer), dNTP mix and MgCl2 were purchased from Fermentas 
(St. Leon, Germany). 
Reaction was carried out in a Primus 96plus thermal cycler (MWG-Biotech, High 
Point, NC, USA). Primers were purchased from MWG. 
 
Protocol: 
PCR mix (50 µl total reaction volume) 
 
• 24.5 µl  MilliQ water 
• 1 µl  template DNA (rTri a 12 in pCR2.1) 
• 5 µl  Primer forward (rTri a 12 exp for) 
• 5 µl  Primer reverse (rTri a 12 exp rev) 
• 4 µl  MgCl2 
• 3 µl  dNTP mix 
• 5 µl   Taq polymerase 
buffer 
• 1.5 µl  Taq 
polymerase  
 
PCR program: 
• 95°C  3’ 
   
• 95°C  1’ 
• 61°C (T A) 1’      35x 
• 72°C (T X) 2’ 
 
• 72°C  10’ 
• 4°C  ∞ 
 
The resulting PCR product was ligated into the cloning vector pCR4-TOPO and 
competent Nova blue E. coli cells were transformed. After plasmid preparation, 
Fig.10: pCR4 TOPO vector (Copyright: Invitrogen, 
Carlsbad, CA, USA) 
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a  DNA sequencing experiment was performed. (For detailed information on 
ligation see chapter 1.10.1, for transformation see chapter 1.10.2, for plasmid 
DNA preparation chapter 1.12 and DNA sequencing see chapters 1.13 and 
1.14). 
2.3.2 Competent cells (E. coli  BL21(DE3) & E. coli  Nova Blue) 
Two kinds of bacteria were used in this study: 
• Nova blue E. coli (Novagen, Madison, WI, USA ) 
• BL21(DE3) E. coli (Invitrogen Corp., Carlsbad, CA, USA) 
Nova blue E. coli cells were used as an amplification site for the cloning vector 
pCR4-TOPO and for the expression vector pET17b. BL21(DE3) E. coli cells are 
used for the expression of rTri a 12. Both strains were treated under chilling 
conditions with SEM buffer (contains divalent cations such as CaCl2) to induce 
competence by weakening bacterial cells wall integrity. 
 
Material: 
• BL 21(DE3)/Nova blue overnight culture 
• SOC medium 
• Tetracycline (5 mg/ml; Nova blue cells only) 
• SEM buffer 
• DMSO (100%; Sigma) 
• Liquid nitrogen 
 
Protocol: 
A BL21(DE3) (or Nova Blue) E. coli over night culture (1 ml) was diluted in 50 
ml SOC (for Nova Blue cells: SOC + tetracycline) and grown in a 250 ml 
Erlenmeyer flask at 30° until an optical density (O D600nm) of 0,6 was reached. 
After ten minutes on ice the culture was transferred into 50 ml Falcon tubes. 
Centrifugation was performed at 2,200 g at 4°C for ten minutes. The resulting 
pellet was resuspended in 16 ml ice cold SEM buffer. After ten minutes on ice 
the suspension was centrifuged at 2,200 g at 4°C fo r ten minutes. The resulting 
pellet was resuspended in 4 ml SEM buffer (on ice) and 280 µl DMSO were 
added. Following ten minute incubation on ice the now competent cells were 
frozen in liquid nitrogen. 
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After plasmid DNA preparation, sequencing experiments were performed (for 
detailed procedures on plasmid DNA preparation see chapter 1.12, for 
sequencing see chapters 1.13 and 1.14). 
 
After obtaining a clone containing the proper restriction sites, the expression 
vector and the plasmid containing rTri a 12 (with NdeI and EcoRI restriction 
sites) were digested with NdeI and EcoRI. 
2.3.3 Double Digest 
For more detailed background information on restriction enzymes see chapter 
1.14. Both, insert (rTri a 12) and vector (pET17b), were digested with NdeI 
(CA|TATG) and EcoRI (G|AATTC). Both enzymes produce sticky ends.  
 
Material: 
• pCR4 cloning vector containing insert (Invitrogen Corp., Carlsbad, CA, 
USA) 
• pET17b expression vector (fig. 11&12; Novagen, Madison, WI, USA) 
• 10x fast digest buffer 
• Fast digest enzyme NdeI 
• Fast digest enzyme EcoRI 
 
Fast Digest restriction enzymes 
and 10x Fast Digest buffer were 
purchased from Fermentas (St. 
Leon, Germany). All reactions were 
carried out in a Primus 96plus 
thermal cycler (MWG-Biotech, High 
Point, NC, USA). 
 
Protocol: 
Fast digest (NdeI/EcoRI) of pCR4 
(including wheat profilin insert) 
Reaction mix (20 µl total reaction 
Fig.11: pET17b vector map (used restriction sites marked by red 
frames) ; (Copyright: Novagen, Madison, WI, USA) 
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volume): 
• 16 µl plasmid DNA  
• 2 µl 10x fast digest buffer 
• 1 µl fast digest enzyme (NdeI) 
• 37°C 30‘  
• 65°C 5‘  
• 1 µl fast digest enzyme (EcoRI) 
• 37°C 30‘  
• 65°C 5‘  
  
Fast digest (NdeI/EcoRI) of pET17b (expression vector)  
Reaction mix (20 µl total reaction volume): 
• 13.5 µl MilliQ water 
• 2 µl 10x fast digest buffer 
• 2.5 µl pET17b (0.4 µg/µl) 
• 1 µl fast digest enzyme (NdeI) 
• 37°C 30‘  
• 65°C 5‘  
• 1 µl fast digest enzyme (EcoRI) 
• 37°C 30‘  
• 65°C 5‘  
2.3.4 Dephosphorylation  
The digested vector was dephosphorylated with calf intestine alkaline 
phosphatase (removes 5’ and 3’ phosphates) to prevent re-ligation. 
Material: 
• Double digested pET17b 
Fig. 12: pET17b cloning site (used restriction sites in marked by red frame); (Copyright: Novagen, Madison, WI, 
USA) 
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• 10x CIAP buffer 
• CIAP (1U/µl) 
CIAP and 10x CIAP buffer were purchased from Fermentas (Hilden, Germany) 
Reaction was carried out in a Primus 96plus thermal cycler (MWG-Biotech, High 
Point, NC, USA). 
 
Protocol: 
Reaction mix (20 µl total reaction volume): 
• 16 µl double digest of pET17b 
• 2 µl  10x CIAP buffer 
• 2 µl CIAP (1U/µl) 
• 37°C 30’ 
• 65°C 15’ 
 
The total amount of digested pET17b and wheat profilin insert was loaded onto 
a 1.2% agarose gel. (for detailed procedures see Chapter 1.8). 
After confirming the presence of vector and insert by agarose gel 
electrophoresis, gel extraction was performed (for detailed procedures see 
chapter 1.9). 
2.3.5 Ligation  
To combine the digested and dephosphorylated vector with the digested wheat 
profilin insert, a ligation reaction was performed. 
Material: 
• digested, dephosphorylated pET17b vector 
• digested wheat profilin insert 
• 10x fast link buffer 
• 10mM ATP 
• sterile MilliQ water  
• Fast link DNA ligase (2 U/µl) 
Fast link ligase, 10 mM ATP and the 10x fast link buffer were purchased 
from Licor (Lincoln, NE, USA) 
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Protocol: 
Reaction mix (20 µl total reaction volume): 
• 6 µl insert  
• 3 µl vector (0.4 µg/µl) 
• 1.5 µl 10x fast link buffer 
• 1.5 µl 10 mM ATP 
• 2 µl sterile MilliQ water 
• 1 µl ligase 
• 22°C 30’  
• 70°C 15’  
To confirm the success of the ligation, agarose gel electrophoresis was 
performed (For detailed procedures see chapter 1.8). Competent Nova Blue E. 
coli cells were transformed with the ligation product (for detailed transformation 
procedures see chapter 1.10.2). Positive clones were selected on tetracycline 
and ampicillin containing LB-agar plates.  
 
Several colonies were picked, analyzed by a PCR colony screen (For detailed 
procedures see chapters 1.7.2 + 1.7.3; for primers see chapter 2.3.1), and 
positive clones were sequenced (for detailed procedures see chapter 1.14). 
 
Competent BL 21(DE3) E. coli cells were transformed with the correctly ligated 
plasmid (For detailed procedures see chapter 1.10.2). 
2.3.6 Small Scale Expression Study 
To assess the efficiency of rTri a 12 expression in BL21(DE3) E. coli cells, a 
small scale expression experiment was conducted. 
 
Material: 
• Transformed BL21(DE3) E. coli cells 
• BL21(DE3) E. coli cells 
• LB ampicillin medium 
• IPTG 
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Protocol: 
Five clones were picked and cultivated in ampicillin containing LB medium (LB-
amp) over night at 30°C. 1.5 ml over night culture were diluted (in 30 ml LB-
Amp medium) and grown to an optical density (OD600) of 0.4. At this point, 0.4 
mM IPTG was added to induce expression. Aliquots(0.5 ml) of the samples 
were taken at three consecutive time points (OD 0.4 being hour 0). 
The aliquoted cultures were centrifuged at 13, 200 rpm for two minutes. The 
supernatant was discarded and the pellet resuspended in 100 µl 1x sample 
buffer. 
2.3.7 Fermentation 
A fermenter is used to cultivate bacteria on a larger scale. Here it is used as a 
means to produce rTri a 12 in sufficient quantity under controlled conditions (air 
supply, temperature regulator).  
 
Material: 
• 2L Fermenter (Ochs GmbH, Bovenden / Lenglern, Germany) 
• LB-ampicillin medium 
• overnight BL21(DE3) E. coli cell culture 
• IPTG 
 
Protocol: 
A fermenter (maximum capacity: 2 litres) was used for the large scale 
expression of rTri a 12. 1.6 l of LB-ampicillin (0.1 mg/ml) medium were 
inoculated with 80 ml overnight E. coli culture (BL21 (DE3)) and grown at 30°C. 
After the bacterial culture reached an OD600nm = 0.4, IPTG was added (0.4mM). 
The cultivation was continued for 5h. Then the bacteria were transferred into 
GS3 tubes and centrifuged at 7,000 g, at 4°C for 30  minutes. Pellets were 
stored at -20°C. 
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3. Purification 
3.1 Overview 
 
 
Fig.13: Purification overview 
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3.2 Buffers & Solutions 
3.2.1 Column preparation buffers 
Lysis buffer     Coupling buffer 
50 mM  NaH2PO4    0.2 M sodium borate, pH 8.5 
300 mM NaCl     10% isopropanol 
10 mM imidazol 
 
Blocking buffer     Wash buffer 1  
1M ethanolamine, pH 8.0    0.2 M sodium acetate, pH 4.0 
      10% isopropanol 
 
Wash buffer 2     Wash buffer 3 
0.2 M sodium borate, pH 8.5   0.2 M sodium borate, pH 8.5 
0.5 M NaCl 
3.2.2 Protein purification buffers   
Start buffer     Wash buffer  
50 mM Tris-HCl, pH 7.4    50 mM Tris-HCl, pH 7.4 
150 mM NaCl     150 mM NaCl 
1 mM EDTA      1 mM EDTA 
1 mM DTT             2 M urea 
                              1 mM DTT 
 
Elution buffer    Column regeneration buffer 
50 mM Tris-HCl, pH 7.4    50 mM Tris-HCl, pH 7.4 
150 mM NaCl     150 mM NaCl 
1 mM EDTA     1 mM EDTA 
6 M urea     8 M urea 
1 mM DTT 
3.2.3 Refolding buffers 
Dialysis buffer 1     Dialysis buffer 2 
50 mM Tris-HCl, pH 7.4    50 mM Tris-HCl, pH 7.4 
150 mM NaCl     150 mM NaCl 
1 mM EDTA     1 mM EDTA 
4 M urea     2 M urea 
1 mM DTT     1 mM DTT 
 
Dialysis buffer 3    Dialysis buffer 4 
50 mM Tris-HCl, pH 7.4    5 mM Na2HPO4, pH 7.2 
150 mM NaCl 
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1 mM EDTA 
1 mM DTT 
3.3 French Press 
After harvesting bacterial cells, disruption was performed using a French Press 
(fig.14). A French Press is a cell disruption method based on high pressure. 
 
Material:  
• French Press FA-031;(Spectronic Unicam, Cambridge, UK) 
• Lysis buffer 
• Cultivated BL21(DE3) 
• Protease Inhibitor (Roche Diagnostics, Mannheim, Germany) 
 
Protocol: 
Cell pellets were resuspended in 30 ml 
lysis buffer on ice. To prevent 
degradation of rTri a 12, a protease 
inhibitor was added (one tablet 
Complete Protease Inhibitor). This 
suspension was filled in the French 
Pressure Cell, where it was disrupted 
three times (900-1, 000 psi). The 
resulting lysate was filled into SS34 
tubes and centrifuged for 45 minutes 
at 14, 000 g. The supernatant and 
pellets were stored at 4°C. 
Samples of the (in)soluble fractions 
were prepared for 15% SDS-PAGE 
under denaturing condition (for 
detailed information on SDS-PAGE see 
chapter 4.3.1). 
3.4 Affinity Chromatography 
In the cell, profilin’s ligands are actin, phosphoinositides, poly-L-proline (PLP) 
and proteins with proline-rich motifs [76]. For that reason poly-L-proline is used 
Fig.14: schematics of French press (Copyright:[74]) 
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as a hook to catch trapped profilin. Purification of rTri a 12 was performed by 
affinity chromatography. The underlying principle of this method is, that a matrix 
(CNBr-activated Sepharose) coupled ligand (poly-L-proline) will bind to profilin, 
discriminating all other proteins [75]. As urea is able to disrupt non-covalent 
bonds in proteins, it is used here (in buffer solutions) to elute purified profilin 
from the chromatography column. 
 
Material: 
Chromatography Column 
• Chromatography column, diameter: 10 mm, length: 20cm (GE 
Healthcare, Uppsala, Sweden) 
• CNBr-activated Sepharose 4B (Amersham Biosciences, Amersham, UK) 
• Poly-L-proline, average MW 5000 (Sigma Aldrich,  St. Louis, MO, USA) 
• 1 mM HCl 
• Coupling buffer 
• Blocking buffer 
• Wash buffer 1-3 
Sample preparation 
• BL21(DE3) E. coli lysate 
• 0.45 µm filter + syringe 
Chromatography run 
• Start buffer 
• Wash buffer 
• Elution buffer 
• Column regeneration buffer 
• FPLC system ÄKTA (GE-Healthcare Biosciences, Amersham, UK) 
 
All buffers were filtered and degassed. 
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Protocol:  
Chromatography Column 
First, 17.5 mg poly-L-proline were dissolved in 7 ml coupling buffer. A 100 µl 
aliquot was taken for photometric analysis of the efficiency of coupling 
(absorption at 214 nm). CNBr-activated Sepharose 4B (1 g) was transferred into 
a frit. A vacuum pump was used to filter 200 ml 1mM HCl through and thus let 
the Sepharose swell. The poly-L-proline solution and the swollen Sepharose 
were combined in a 50 ml Falcon tube and incubated under stirring at room 
temperature for 2 hours. 
Afterwards the tube was centrifuged and the supernatant was analyzed 
photometrically, along with the aliquot from the poly-L-proline solution prior to 
coupling. 
The gel was transferred to a chromatography column, where it was washed with 
wash buffer 1-3 and coupling buffer using a peristaltic pump.  
 
Sample preparation 
Before the E. coli lysate was applied to the column, it was dialysed (for detailed 
information on dialysis see chapter 3.5) against start buffer and also it was 
filtered by using a 0.45 µm sterile filter. 
 
Chromatography run 
The chromatography column was equilibrated with 18 ml (6-fold column 
volume) start buffer. Purification of rTri a 12 was achieved by using FPLC 
system ÄKTA. The chromatography column was connected to the ÄKTA FPLC 
system. Pump A (wash buffer), Pump B (elution buffer), sample pump and 
injection valve were washed with MilliQ water. Afterwards pump A was washed 
with wash buffer and pump B with elution buffer. The sample was applied to the 
FPLC/Chromatography system at a flow rate of 1 ml per minute. Fraction size 
was 9 ml (3-fold CV).  
After completing the loading process a stepwise elution was performed. The 
first elution step was a buffer containing 1.5 M urea, the second step was 
performed with a buffer containing  4.5 M urea and the third step was done with 
buffer containing 6 M urea (100% elution buffer). All fractions were collected 
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and analyzed in a SDS PAGE (15%), followed by Coomassie staining. The 
column was washed with MilliQ-water, with column regeneration buffer and 
stored at 4°C. 
3.5 Dialysis 
To obtain folded protein and to get rid of small size contaminations, dialysis was 
performed. Also salt and urea do not provide a stable environment for long term 
storing of protein, therefore a sodium phosphate buffer solution was used as the 
final buffer during dialysis. 
 
Material: 
• Dialysis membrane (MWCO: 1,000 Da, 1 ml/cm);( Spectra/Por, Breda, 
NL) 
• rTri a 12 solution 
• Dialysis buffer 1-4 
 
Protocol: 
Total sample volume was 12 ml, therefore 18 cm of dialysis membrane were 
used. After carefully transferring the sample unto the membrane, it was closed 
on each side with clamps. Dialyzing was performed using three litres of 
respective buffer, overnight at 4°C under constant stirring.The final dialysate 
was stored at -20°C. 
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4. Characterisation 
4.1 Overview 
 
Fig.15: Characterisation overview 
 
4.2 Buffers & Solutions 
Reagent C 
29.2% acryl amide 
0.8% bisacryl amide 
dissolved in distilled water and filtered 
 
Lower buffer    Upper buffer 
1.5 M Tris-HCl, pH 8.8    0.5 M Tris-HCl, pH 6.8  
0.4% SDS     0.4% SDS 
dissolved in distilled water    dissolved in distilled water 
 
4x Sample buffer    10x Electrophoresis buffer   
200 mM Tris-HCl, pH 6.8    250 mM Tris pure 
300 mM DTT     192 mM glycine 
4% SDS      1% SDS 
40% glycerine     dissolved in distilled water  
0.04% bromophenol blue 
dissolved in distilled water 
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CBB      Destainer 
0.125% CBB R-250    20% Methanol 
50% Methanol     15% HAc 
10% HAc      dissolved in distilled water 
dissolved in distilled water 
 
10x transfer buffer   1x transfer buffer 
250 mM Tris pure     diluted 10x transfer buffer 
192 mM Glycine     20% Methanol 
MilliQ water 
 
10x TBS      TBST 
0.5 M Tris-HCl, pH 7.4    1x TBS 
1.5 M NaCl     0.5% Tween 20 
0.5% NaN3     MilliQ water 
     
1x AP buffer    Gold buffer:   
100 mM Tris-HCl, pH 9.5    42 mM Na2HPO4 x 12 H2O 
100 mM NaCl     8 mM NaH2PO4 x 2 H2O 
5 mM MgCl2     0.05% NaN3 
MilliQ  water      pH 7.5 
0.5% Tween 20 
 
4.3 Characterisation 
SDS-PAGE was performed to separate the proteins obtained by affinity 
chromatography. Following the determination of the proteins’ concentration by 
BCA [78], a LAL test was performed to determine the level of contamination by 
bacterial endotoxin. A circular dichroism procedure gave information about the 
structural integrity and the thermostability of rTri a 12. N-terminal sequencing 
revealed the first five amino acids of the protein, whereas mass spectrometry 
was performed to obtain the intact mass of rTri a 12. The following experiments 
were conducted to obtain information about rTri a 12 IgE binding properties: IgE 
blot, IgE inhibition blot and IgE ELISA.   
4.3.1 SDS-PAGE 
SDS-PAGE is a method used to separate proteins according to their molecular 
weight (electrophoresis). SDS is an anionic detergent, which denatures 
proteins. Its main functions are occupying polypeptide backbones of proteins, 
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blocking of hydrophobic interactions and disruption of hydrogen bonds. These 
abilities lead to linearization and negative charging of SDS treated proteins. 
With all proteins denatured and negatively charged, an electrophoretic 
separation is feasible. 
DTT is added to break up disulfide bonds, which leads to loss of tertiary and 
quaternary structures. 
The most frequently used buffer system for SDS-PAGE is the tris-glycine 
system described by Laemmli [77]. 
Material: 
• Reagent C 
• Upper buffer 
• Lower buffer      
• 4x sample buffer      
• 10x electrophoresis buffer 
• Sample 
• rBet v 2 (1mg/ml; Biomay, Vienna) 
• Protein marker (fig.16; Fermentas, Hilden, 
Germany) 
• CBB 
• Destainer 
 
Chemicals Resolving Gel Stacking Gel 
Reagent C 2.5 ml  300 µl 
Lower buffer 1.25 ml - 
Upper buffer - 500 µl 
ddH2O 1.25 ml 1.2 ml 
TEMED 2.5 µl  1 µl 
10% APS 25 µl 20 µl 
Tab. 6: SDS-PAGE gel compositions 
Protocol:  
All samples were mixed with 4x SB and  incubated at 95°C for 10 minutes. After 
the samples were loaded into the gel pockets. Alongside a protein marker, rBet 
v 2 and a lysate from bacteria without pET17b + Tri a 12, the electrophoresis 
was performed for one hour (25 mA). Visualization was achieved by Coomassie 
Brilliant Blue R-250 staining for thirty minutes. Destaining was done overnight. 
Fig.16: protein marker 
(Copyright: 
www.fermentas.com) 
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4.3.2 Bicinchoninic acid protein assay  
To determine the concentration of rTri a 12 a BCA was performed. The BCA 
test is based on the reduction of copper ions (Cu++  Cu+) by proteins (Biuret 
reaction) [78]. The resulting copper ion is then able to form a complex with two 
bicinchoninic acid molecules (chelate). Due to the violet colour of the chelate it 
is possible to measure absorption at 562 nm. More protein results in more 
Biuret reactions, which gives a stronger signal.  
 
Material: 
• BSA Stock solution: 2 mg/ml  
• Sodium phosphate buffer, pH7.2. 
• rTri a 12 in sodium phosphate buffer solution were diluted 1 : 5 and 1 : 10 
in sodium phosphate buffer, pH7.2. 
• Nunc MaxiSorp ELISA plate (96 well plate) 
• Working reagents A+B (Pierce Protein Research Products, Rockford, IL, 
USA ) 
• ELISA READER (molecular devices, CA, USA) 
 
Protocol: 
Standards were made according to manufacturer’s protocol: 
Standard # Buffer  BSA  concentration 
Standard 1 105 µl 15 µl 250 µg/ml 
Standard 2 108 µl 12 µl 200 µg/ml 
Standard 3 111 µl 9 µl 150 µg/ml 
Standard 4 114 µl 6 µl 100 µg/ml 
Standard 5 117 µl 3 µl 50 µg/ml 
Standard 6   60 µl - 0 µg/ml 
Tab. 7: BCA Standard preparation 
After preparing the standards, rTri a 12 sodium phosphate buffer solution was 
diluted 1 : 5 and 1 : 10. Working reagent was produced by mixing reagent A 
with reagent B 50 : 1 (A : B). Twenty five micro litres of standards and sample 
were pipetted (in duplicates) into the wells of a 96-well plate. After the working 
reagent was added (200 µl) to every well, the plate was covered and incubated 
at 37°C for 30 minutes. After five minutes of cooli ng, data were obtained from 
an ELISA reader at 562 nm. 
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4.3.3 Limulus amebocyte lysate test  
A LAL test was performed to measure the contamination of purified rTri a 12 
with bacterial endotoxin. This is a quantitative test for gram-negative bacterial 
endotoxin [79]. Gram-negative bacterial endotoxin catalyses the activation of a 
proenzyme in the Limulus Amebocyte Lysate (LAL). The activated enzyme then 
catalyses the splitting of p-nitroaniline (pNA) from colourless substrate Ac-Ile-
Glu-Ala-Arg-pNA. The pNA released is measured photometrically at 405-410 
nm after the reaction is stopped. The concentration of endotoxin in a sample is 
calculated from the absorbance values of a standard  solution (tab.8). 
Material: 
• LAL reagent water  
• LAL reagent 
• Chromogenic substrate (Ac-Ile-Glu-Ala-Arg-pNA) 
• Sample (rTri a 12) 
• Stop solution (25% acetic acid diluted in LAL Reagent Water) 
• 96 well microplate (Greiner bio-one, Frickenhausen, Germany) 
LAL reagent, water and chromogenic substrate were purchased from Cambrex 
(Walkersville, MD, USA) 
 
Protocol: 
Standards were prepared according to manufacturer’s protocol: 
EU/ml Endotoxin stock Standards LAL reagent water 
1 0.1 ml  (x-1)/10 ml 
0.5  0.5 ml 0.5 ml 
0.25  0.5 ml 1.5 ml 
0.1  0.1 ml 0.9 ml 
Tab. 8: LAL standards 
Escherichia coli endotoxin was reconstituted in 1 ml LAL reagent water and 
mixed vigorously for at least 15 min. The LAL reagent was dissolved in 1.4 ml 
LAL reagent water. Samples were diluted in LAL reagent water in optional 
dilutions. 
To measure the endotoxin concentration of purified rTri a 12, a 96 well 
microtiter plate was heated to 37°C before it was c oated with 50 µl sample, 
standards, and blank (LAL reagent water), in double. Ten minutes after addition 
of 50µl LAL to every well, 100 µl substrate solution (37°C) were added. Six 
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minutes later 100 µl stop solution were added. Optical density was measured at 
405 nm.   
4.3.4 Circular Dichroism 
Circular dichroism (CD) spectroscopy is a type of absorption spectroscopy that 
provides information on the structures of biological macromolecules. CD is the 
difference between the absorption of left and right handed circularly-polarised 
light and is measured as a function of 
wavelength. Chiral or asymmetric 
molecules produce a CD spectrum 
because they absorb left and right 
handed polarised light to different 
extents. Proteins are composed of 
optically active elements and due to 
their adoption of different types of 
three-dimensional structures each 
type of molecule produces a distinct 
CD spectrum (fig.17). Ultraviolet or 
vacuum ultraviolet (190 nm – 300 nm) 
light is best suited for examining the 
structures of proteins. These are the 
regions of the electronic transitions of the peptide backbone and side chains in. 
Peptide bonds dominate between 170-250 nm (fig.17), whereas aromatic amino 
acids do so between 250-300 nm. Disulphide bonds are displayed at 250 nm. 
α-helices produce well defined negative bands at 222 nm, whereas β-sheets 
display less-defined bands at 217 nm. CD spectroscopy requires only very 
small amounts of material (< 100 µg) [80]. 
 
Material: 
• purified rTri a 12 a 
• JASCO J-810 spectropolarimeter (Jasco, Essex, UK) 
• Neslab RTE-11-M temperature control system (Thermo Neslab Inc., 
Newington, NH, USA) 
• quartz cuvette of 0.1 cm path length 
Fig. 17: Example for CD spectrum; structural units 
marked by α-helix, β-strand and loop (r) (Copyright: 
New Science Press) 
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Protocol: 
Spectra of purified rTri a 12 were recorded in aqueous solutions with a 
temperature control system equipped spectropolarimeter. Measurements were 
performed with a quartz cuvette. Far UV CD spectra were recorded at 25°C, 
with a band width of 1 nm, a response time of 1 second, and a data pitch of 1 
nm. Measurement range was between 190 nm and 260 nm and obtained 
spectra represent an average of 3 consecutive scans. Final spectra were 
obtained after subtraction of the baseline recorded under identical conditions. 
All measurements were performed using 5 mM sodium phosphate pH 7.2 and 
protein concentration of 0.1 µg/µl. Thermal denaturation was monitored in the 
temperature range of 25°C to 95°C at a fixed wavele ngth of 210 nm. The 
temperature slope was set at 1°C/min and full CD sp ectra were recorded from 
25°C to 95°C every 10 degrees using the parameters listed above. The 
reversibility of the unfolding process was determined by monitoring a full CD 
spectrum after cooling the denatured protein to 25°C. 
4.3.5 N-terminal sequencing 
Based on the Pehr Victor Edman 
degradation, the sequence of the N-
terminus of proteins can be 
deciphered [81]. The amino acid 
sequence is obtained by labelling 
and (later) cleaving the amino-
terminal residue  without disrupting 
the peptide bonds between the 
following amino acid residues 
(fig.18). 
The uncharged terminal amino 
group reacts with 
phenylisothiocyanate (PITC, Edman reagent) to form a phenylthiocarbamoyl 
derivative. This derivative is cleaved under mildly acidic conditions. The 
resulting molecule is called phenylthiohydantoin (PTH)-amino acid, which can 
be identified by chromatography. This procedure is repeated as often as is 
required to obtain the N-terminal amino acid sequence. A graphic description of 
Fig. 18: Edman chemistry (Copyright: University of 
Montana, division of biological sciences) 
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the Edman degradation is shown in figure X. The coupling of N-terminal amino 
groups of a protein with PITC (top) forming an open chain thiourea derivative 
(middle),  the N-terminal amino acid is split off as anilinothiazolinone (ATZ) 
derivative (bottom) with trifluoroacetic acid (F3CCOOH). This unstable ATZ-
derivative is converted into a more stable PTH derivative, which is separated by 
reversed phase HPLC and identified by comparison with a standard. 
 
Material: 
• 50 pmol rTri a 12 
• Applied Biosystems Procise 491 sequencer (Applied Biosystems, Foster 
City, USA) 
• Prosorb Cartridge 
 
Protocol: 
Fifty pico mol of rTri a 12 were adsorbed on a Prosorb cartridge and analyzed 
with the amino acid sequencer overnight. The resulting sequence was 
compared to the database sequence of Tri a 12 by using the BLAST software. 
 
4.3.6 Mass Spectrometry 
Experiment was performed by Dr. Peter Briza (University of Salzburg, 
Department of Molecular Biology). 
Material: 
• Sample 
• Global Ultima Q-Tof instrument (Waters, Manchester, UK) 
• Horse heart myoglobin (Sigma, St. Louis, USA) 
• Proteoextract trypsin digestion kit (Calbiochem, San Diego, USA) 
• RP-HPLC (Waters, Milford, USA) 
• [Glu]-fibrinopeptide B (Sigma, St. Louis, USA) 
• Jupiter 5µm, C4, 300Å column, 4.6 x 250mm (Phenomenex, 
Aschaffenburg, Germany) 
• guard cartridge, 3 x 4 mm, wide-pore C4, “Security Guard”  
(Phenomenex, Aschaffenburg, Germany) 
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Protocol: 
For mass determination of intact rTri a 12, the protein was dissolved in 25 % 
(v/v) acetonitrile in 0.1% (v/v) aqueous formic at a concentration of 1 pmol/µl 
and directly infused into a Global Ultima Q-Tof instrument with electrospray 
ionization. The infusion rate was 1 µl/min, using the Waters Nanoflow spray 
head with nitrogen as desolvation gas and a capillary voltage of 3.4 kV. The 
instrument was calibrated with horse heart myoglobin. Spectra of multiple 
charged ions were recorded for 3 minutes in a mass/charge range from 400 to 
1900. Spectra were then combined and deconvoluted using the MaxEnt1 
software supplied with the instrument. For sequence analysis, 5 µg of rTri a 12 
were digested with the Proteoextract trypsin digestion kit. The resulting peptides 
were separated by capillary RP-HPLC directly coupled to the mass 
spectrometer (pre-column Waters Nanoease Symmetry300 trap column, 
separating column Waters Nanoease Atlantis dC18, connected via a 10 port 
stream select valve). The flow rate was adjusted to 300 nl/min by T-splitting. 
Peptides were eluted with an acetonitrile gradient (solvent A: 0.1% (v/v) formic 
acid, 5% (v/v) acetonitrile; solvent B: 0.1% (v/v) formic acid, 95% (v/v) 
acetonitrile; 5-45% B in 90 min). For sequence analysis, the instrument was 
calibrated with the fragment ions of [Glu]-fibrinopeptide B. Data were acquired 
in the Data Directed Analysis (DDA) mode. Survey and fragment spectra were 
analyzed using the software PLGS version 2.2.5 with automatic and manual 
data verification. For sequence identification a mini database comprising the 
trypsin and rTri a 12 sequences and a combined SwissProt/Trembl database 
were used. 
Recombinant Tri a 12 was subjected to RP-HPLC with on-line electrospray-
ionization mass spectrometry analysis using a modification of the method of 
Moreno et al. [82]. Recombinant Tri a 12 was dissolved in water and applied to 
a Jupiter 5µm, C4, 300Å column (4.6 x 250mm) equipped with a guard 
cartridge. Peptides were eluted with an acetonitrile gradient (solvent A: 0.1% 
(v/v) trifluoroacetic acid; solvent B: 0.085% (v/v) trifluoroacetic acid, 90% (v/v) 
acetonitrile, 0.9%-90% solvent B in 15 min). Recombinant Tri a 12 was 
analysed by matrix-assisted laser desorption/ionisation-time of flight mass 
spectrometry (MALDI-TOF MS) after in-gel trypsin digestion at the University of 
Salzburg by Dr. Peter Briza (Department of Molecular Biology). 
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4.3.7 IgE blot 
 
Blotting: Blotting is a standard technique for transferring proteins (or nucleic 
acids) from poly acrylamide gels onto a membrane (e.g. 
nitrocellulose). This is achieved by applying an electric current to 
the gel-membrane blot sandwich (fig.19). 
The negatively charged proteins will migrate onto the nitrocellulose 
membrane, as the anode attracts negatively charged molecules. 
 
Material: 
• 10x transfer buffer   
• 1x transfer buffer   
• 10x TBS     
• TBST     
• 1x AP buffer    
• NBT (50 mg/ml in 70% DMF/MilliQ water) 
• BCIP (25 mg/ml in MilliQ water) 
• Whatman paper 
• rTri a 12 
• nitrocellulose membrane 
• IgE antibodies (BD-Biosciences Pharmingen, San Diego, USA) 
• profilin allergic person’s serum and NHS 
 
Protocol: 
rTri a 12 was separated by 15% SDS-PAGE under reducing conditions (for 
detailed procedure see chapter 4.1). The gel was blotted onto a nitrocellulose 
membrane: gel, nitrocellulose membrane and whatman paper were soaked with 
Fig.19: Blotting sandwich 
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1x transfer buffer. The blot sandwich was assembled according to figure 19. 
The blotting procedure was performed for fifty minutes in a Transphor 
Electrophoresis Unit (Hoefer Scientific Instruments, San Francisco, USA) at 4°C 
and 25 mA. After blotting was accomplished the membrane was dried and cut 
into strips. After blocking the strips with TBST + 3% milk powder at RT for 30 
minutes (followed by washing with TBST), strips were incubated with patients’ 
sera (1:5 diluted in TBST + 0.5% BSA) at 4°C over n ight. After removing the 
sera, the strips were washed with TBST for forty minutes (buffer change all 10 
minutes), bound IgE was detected by incubation with alkaline phosphatase 
conjugated anti-human IgE antibodies (1:1000 dilution with TBST + 0.5% BSA) 
at RT for two hours. After washing with TBST for thirty minutes the membrane 
was equilibrated with AP buffer. To visualise bound IgE, BCIP (60 µl) and NBT 
(60µl) were diluted in 10 ml AP buffer. The membrane strips were incubated in 
this solution for five minutes at room temperature in the dark. The reaction was 
stopped with deionized water. 
4.3.8 IgE Inhibition 
In this experiment the IgE binding capacity of purified rTri a 12 and of natural 
wheat profilin was compared. Natural wheat profilin was extracted from wheat 
seeds. 
 
Material: 
• wheat seed extract 
• profilin allergic patients serum, normal human serum (NHS) 
• rTri a 12 
• rBet v 2 (Biomay, Vienna, Austria)  
• Gold buffer 
• Milk powder, BSA 
• IgE 125I antibody (MedPro, Vienna, Austria) 
• Blotting material (see IgE Blot chapter 4.7) 
 
MATERIALS and METHODS 
67 
 
 
Protocol: 
Diluted patient’s sera (1:5 in Gold buffer + 0.5% BSA) were incubated with 
either rTri a 12 (100µg/ml) or rBet v 2 (100 µg/ml) for two hours. Buffer- and 
NHS served as negative controls. 
An extract from ground wheat corn (T. aestivum cv. Edison) was separated via 
SDS PAGE (80 µl wheat seed extract) and blotted onto a nitrocellulose 
membrane (see chapter 4.3.7). Afterwards the membrane was cut in 4 mm 
broad strips. The strips were blocked for forty minutes with gold buffer/3% milk 
powder. After washing with gold buffer for ten minutes, the strips were 
incubated with diluted serum (see above) overnight at 4°C. Bound IgE was 
detected with I125 labelled anti-human IgE (1:40; diluted in 50 mmol/L sodium 
phosphate buffer/0.5%Tween 20/1% BSA pH 7.5) and visualised by 
autoradiography. NHS and buffer controls were included. 
4.3.9 IgE ELISA 
ELISA is a widely used technique in immunological research. Usually, the assay 
employs two antibodies. The first antibody recognizes the allergen. The second 
antibody binds to the first antibody. The second antibody is coupled to an 
enzyme (e.g. alkaline phosphatase), which catalyzes a colourless, chromogenic 
substrate to a quantifiable dyed product. 
 
Material: 
• MaxiSorp 96 well plate (Nunc; Roskilde, Denmark) 
• 25 mM NaHCO3, pH 9.5 (coating buffer) 
• TBST, milk powder, BSA 
• Wheat allergic patients’ sera, Baker asthmatics’ sera, and NHS 
• Purified rTri a 12  
• Monoclonal anti human IgE Antibody (BD-Biosciences Pharmingen, San 
Diego, USA), alkaline phosphatase labelled 
• p-nitrophenyl phosphate tablets, to prepare 5 ml (Sigma, St. Louis, USA) 
• ELISA reader (Spectra Max plus 384; Molecular Devices GmbH, Munich, 
Germany) 
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Protocol: 
Purified rTri a 12 was diluted in 25 mM NaHCO3 (pH 9.6) to a concentration of 
10 µg/ml. The 96 well plate was coated with 1 µg protein per well and incubated 
at 4°C over night. Following the disposition of the  coating solution, the plate was 
washed three times with TBST. After two hours of blocking with 200 µl 
TBST+3% milk powder (at room temperature), the plate was washed again with 
TBST(3x). Sera were diluted in 1:5 TBST+0.5% BSA. The 96-well plate was 
incubated with sera from wheat allergic patients overnight at 4°C. After 
removing the sera and washing the plate three times with TBST, alkaline 
phosphatase-conjugated mouse anti-human IgE antibody (1:1000; TBST+0.5% 
BSA) was added. After incubating the plate for two hours in the dark (RT) the 
wells were washed again three times with TBST. The assay was developed with 
the p-nitrophenyl phosphate substrate. Optical density values from normal 
human serum samples were obtained and standard deviation calculated. All OD 
values from serum samples above mean value plus 3x standard deviations 
were considered positive. 
The experiment was repeated with 25 sera from wheat allergic- and baker 
asthmatic patients (provided by the Floridsdofer Allergiezentrum, Vienna, 
Austria). An IgE ELISA was also performed with Tri a 19 instead of rTri a 12. 
Conditions were the same as for the rTri a 12 ELISA (including the sera).  
4.3.10 Sera 
Sera of wheat allergic patients were selected according to convincing case 
history, based on their clinical symptoms after ingestion of wheat and 
subsequent positive skin prick test (SPT) and CAP/RAST. Sera were provided 
by EUROPREVALL serum bank (n = 8; sera B207-B214) and by Dr. Wolfgang 
Hemmer from the Floridsdofer Allergiezentrum (n = 25; Vienna, Austria). For 
detailed information on patient’s case history, age and diagnosis results see 
table 9. 
As negative control, normal human sera (NHS) from non-responding, non-
allergic individuals were used. 
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Patient Age History SPT  RAST (class) CAP (kUA/l) 
1594 19 Rhinitis Wheat 
Rye 
Oat 
w 2.2 
r 2.0 
100 
1826 42 Rhinitis 
respiratory 
symptom 
Wheat  
Rye 
w 4.5   
r 4.8 
700 
3115 22 respiratory 
symptom 
neg w 2.8 
r 2.9  
50 
3238 56 Wheat allergy Wheat  w 3.4 30 
3243 24 respiratory 
symptom 
Wheat 
Oat 
w 2.4   190 
3261 76 angiooedema  Wheat 
Rye 
w 2.8 30 
3306 43 Baker 
respiratory 
symptom 
Wheat  w 3.6 
r 2.2 
1000 
3322 18 Confectioner 
Dermatitis  
neg w 2.1  
r  2.0   
b 2.0 
60 
3383 50 Wheat allergy neg w 3.3 
o 2.0 
360 
3400 31 Confectioner  
Rhinitis  
nt w 2.5 
r 2.6 
260 
3407 45 Wheat allergy neg w 2.5 290 
3422 37 Pizza cook 
Rhinitis  
nt w 2.0 2000 
3486 49 Respiratory 
symptom 
nt w 2.4  
r 2.3 
930 
3523 22 Wheat allergy neg w 2.4 170 
3699 24 Confectioner 
Rhinitis 
nt w 2.3 30 
3869 41 Wheat allergy neg w 2.2 100 
3889 20 Baker  
Rhinitis 
Wheat  w 2.2 
r  2.3   
600 
3901 70 baker nt w 2.2 
r 2.1 
20 
3906 26 Wheat allergy Wheat  w 2.3 240 
3956 23 Wheat allergy neg w 4.0 80 
3962 33 Wheat allergy 
Exantheme 
Wheat  w 2.5 330 
3971 52 Wheat allergy Wheat  w 2.7 470 
3980 40 Wheat allergy Wheat  w 3.0 40 
4083 22 Baker 
  
neg w 2.0 
r 3.4 
760 
4220 33 Wheat allergy Wheat  w 2.0 140 
Tab. 9: patients index; nt = not tested; neg = negative; w = wheat; r = rye; o = oat; b = barley 
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III. RESULTS 
1. Cloning 
Total RNA was isolated from 2 days old wheat sprouts. RNA extract was 
investigated via a photometric scan and agarose gel electrophoresis. 
Complementary DNA first strand synthesis was performed using total RNA 
extract and a T25NN primer. This was followed by PCR with gene specific 
primers. The PCR product was cloned into the cloning vector pCR2.1. Following 
transformation of TOP10 E. coli cells, single clones were isolated and the 
respective inserts sequenced (ClustalW, Transseq). 
The RNA spectrophotometric scan (Fig.20) and the RNA gel electrophoresis 
(Fig.21) demonstrated the successful isolation of RNA from two days old wheat 
sprouts (severed from seed). The spectrum showed the expected peak at 260 
nm and the 28S and 18S RNA signals are clearly visible on the RNA agarose 
gel (fig.21;lane 2). 
To assess the quality of the extracted RNA the optical density OD260nm/OD280nm) 
ratio was determined.  
 
 
Fig.20: photometric  wavelength scan of total RNA extract 
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OD260nm  = 0.759 
OD280nm = 0.381 
OD260nm/OD280nm = 1.986  
          
  
 
 
 
 
 
 
To calculate the RNA concentration the following formula was used: 
 
 
 
RNA-concentration = 607.2 µg/mL 
 
 
 
 
 
Fig.21: agarose gel electrophoresis of total RNA 
extract 
Fig.23: agarose gel electrophoresis of profilin 
PCR-product 
Fig.22: agarose gel electrophoresis f rubisco 
PCR-product 
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Complementary DNA synthesis was performed using a T25NN primer.  
 
 
        
 
 
 
 
 
 
 
 
 
The rubisco (ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit) 
housekeeping gene served as a control for the integrity of the obtained cDNA. 
PCR was performed successfully for a rubisco gene fragment of 331 bp (fig.22; 
lane 2). 
PCR was performed to amplify profilin encoding sequences (from cDNA). 
Primers were designed according to available wheat profilin sequences. With an 
annealing temperature of 60°C a weak signal at 396 bp (fig.23; lane 2) was 
visible in agarose gel electrophoresis. 
To obtain a stronger PCR signal the first PCR product was extracted from the 
agarose gel and then used as a template for another PCR. The annealing 
temperature was raised by one degree to 61°C to min imize unspecific 
amplification of PCR product, resulting in a stronger signal (Fig. 24, lane 2) at 
396 bp.  
After ligation of the PCR product into the pCR2.1 vector, competent E. coli TOP 
10 cells were transformed. Single colonies of the transformed E. coli were 
cultivated and later plated onto LB-amp-x-gal medium petri dishes. Following 
transformation picked colonies (fig.25) were analysed further by plasmid DNA 
preparation and restriction analysis. Subsequently, DNA sequencing was 
performed. 
 
 
Fig.25: colonies of transformed TOP10 E. coli on 
LB-amp/xGal medium 
Fig.24: agarose gel electrophoresis of gelexPCR 
 
RESULTS 
73 
 
 
The EcoRI digest of the pCR2.1 Vector 
(including the insert) showed signals of 
the plasmid (fig.26, lane 2, top) and the 
insert (fig.26, lane 2, bottom) in the 
expected range. 
 
 
 
 
 
 
 
 
1.1 Sequence analysis 
Fig.26: agarose gel electrophoresis of digested 
cloning vector plus insert 
RESULTS 
74 
 
 
None of the sequenced clones matched exactly the database entry (homology: 
98%, fig.27).There were differences in the DNA sequence at eight positions 
(fig.27, red arrows), which resulted in two different amino acid residues (fig.28). 
Compared to the protein database entry of the wheat (Triticum aestivum) profilin 
isoform 3 (there are two differences in the amino acid sequence. At position 20 
(fig.28) the clone shows a histidine residue, whereas the database profilin 
shows an asparagine residue. At position 48 (fig.28) an isoleucin replaces the 
asparagine of the database sequence. 
Profilin amino acid sequences of other, closely related plants, show homology 
with the clone at positions 20 and 48 (fig.28).  
Fig.27: DNA sequence alignment between the obtained sequence (CLONE_3R) and the published wheat profilin 
sequence (AccNr.: X89827). The sequence of CLONE_3R showed a length of 396 bp, compared to 394 bp of the 
database sequence. Differences between the two sequences are marked by red arrows. 
Fig.28: amino acid sequence alignment between the obtained sequence and the published sequences from 
wheat (Triticum-DB; AccNr.:P49234), barley (Hordeum;AccNr.:AAA92503), maize (zea; AccNr.: NP001105450), 
and timothy grass (phleum; AccNr.: ABG81290). Differences of interest are marked by arrows. 
RESULTS 
75 
 
Other differences in the amino acid sequence occurred at position 4, 31, 129 & 
130 (fig.28). At position 4 the clone sequence and the sequence of wheat 
profilin isoform three matched (both lysine), whereas all other sequences 
showed a glutamine residue. At positions 31, 129 and 130 the clone sequence 
and the database entry of wheat profilin matched, all other sequences differed 
from that at these positions.  
A theoretical mass of 14,032 kDa and a theoretical pI of 5.04 were determined 
by Protparam. 
 
2. Expression 
PCR was performed with primers including NdeI and EcoRI restriction sites. 
After a double digest of profilin insert and pET17b with NdeI and EcoRI, vector 
and insert were ligated. After transformation of BL21(DE3) E. coli cells, several 
colonies were picked, sequenced and cultivated. One clone was chosen for a 
small scale expression experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
NdeI and EcoRI restriction sites were added via PCR to the wheat profilin 
sequence.The resulting product showed a length of 405 bp (fig.29, lane 2). 
Digested expression vector/profilin-insert construct showed two bands in 
agarose gel electrophoresis. One band was visible at 3,300 bp, which 
represents the digested pET17b vector (fig.30, lane 2, top). The other signal 
Fig.29: agarose gel electrophoresis of wheat 
profilin PCR-product (with added restriction sites) 
Fig.30: agarose gel electrophoresis of 
NdeI/EcoRI digested expression vector 
containing insert 
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was visible at 399 bp (fig.30; lane 2, bottom), which represents the digested 
insert. 
 
 
 
 
 
 
 
 
 
 
 
 
After transformation of BL21(DE3) E. coli several colonies (fig.31; marked by 
arrows) were picked for further analysis. Agarose gel electrophoresis of PCR 
colony screens confirmed the presence of wheat profilin (405 bp band) in the 
genetic makeup of the bacteria of that colony (fig.32).  
After the PCR colony screen, a plasmid DNA preparation was performed, 
followed by the DNA sequencing thereof. Sequence analysis showed that all 
clones contained the profilin DNA sequence (fig.33). 
One clone with the correct sequence is shown in figure 33. The profilin 
sequence is flanked by the correct restriction sites (fig.33: NdeI at the 5’ end, 
and EcoRI at the 3’ end; in orange) and the pET17b DNA (fig.33; in red). 
  
 
 
 
 
 
 
 
Fig.33: DNA sequence of clone containing the flanking regions of pET17b in red, NdeI and EcoRI 
restriction sites in orange, profilin sequence in black. 
5‘-TTTAAGAAGGAGATATACATATGTCGTGGAAGGCGTACGTCGACGACCACCTGTGCT 
GCGAGATCGACGGCCAGCACCTCACCTCCGCCGCCATCCTCGGCCACGACGGCAGCGT
CTGGGCGCAGTCCCCCAACTTCCCCCAGTTCAAGCCTGAGGAGATTGCTGGCATCGTTA
AAGACTTTGAAGAACCTGGACACCTTGCACCAACTGGTCTTTTCCTTGGGGGCACAAAGT
ACATGGTCATCCAAGGTGAACCTGGGGTTGTCATCCGAGGAAAGAAGGGCACCGGTGG
CATCACTATCAAGAAGACGGGCATGGCCCTGATTCTCGGTATCTACGATGAGCCCATGA
CTCCTGGCCAGTGCAATTTGGTCGTGGAGAGGCTCGGCGATTACCTGATCGATCAGGGT
TACTAAGAATTCTGCAGATATCCATCACA - 3‘ 
Fig.31: colonies of transformed BL21(DE3) E. coli 
cells on LB-amp plate (picked colonies are 
marked by arrows) 
Fig.32: agarose gel electrophoresis of a PCR 
colony screen, which confirmed the presence of 
wheat profilin 
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Fig.34: SDS-PAGE (15%) of BL21(DE3) E. coli protein extract containing 
rTri a 12 (lanes 3-5) compared to BL21(DE3) E. coli protein extract without  
rTri a 12 (lanes 6-8). rBet v 2 served as positive control (lane 2) 
 
In SDS-PAGE (15%) a strong band at 14 kDa was detectable in the BL21(DE3) 
batches, which corresponds to expressed rTri a 12 (lanes 3-5; 0-4h). Even 
without IPTG a moderate level of expression was achieved (fig.34, lane 3, 0h). 
After the addition of IPTG, strong bands were visible at 14 kDa after two and 
four hours (fig.34, lanes 4&5, 2h&4h) post induction. In contrast, bacteria 
without rTri a 12 showed no comparable signals at 14 kDa (fig.34, lanes 6-8). 
Birch pollen profilin served as appositive control (fig.34, lane 2).  
3. Purification 
Following E. coli harvest, purification of rTri a12 from the soluble fraction was 
achieved by affinity chromatography. After dialysis to a suitable storage buffer 
(5 mM Na2HPO4, pH 7.2), SDS-PAGE was performed to check the success of 
the purification (dialysis). 
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Fig.35: chromatogram of BL21(DE3) E. coli expressing rTri a 12, loaded onto a poly-L-proline 
chromatography column 
Elution of rTri a 12 was achieved by a stepwise increase in the urea 
concentration of the elution buffer (fig.35, buffer B). The highest concentration 
of urea (buffer B) showed the best results, regarding rTri a 12 elution. Collected 
fractions (fig. 35, fractions 8-15) were analyzed further by SDS-PAGE (fig.36) 
 
Fig.36: SDS-PAGE (15%) analysis of rTri a12 purification: E.coli lysate was purified by poly-L- 
proline affinity chromatography. 
lane 1: protein marker; lane 2: purified rBet v 2; lane 3-7: flow through fractions; lanes 8-10: elution 
fractions 11-13.  
 
Fractions 11, 12 and 13 contained a high amount of purified rTri a 12 (fig.36, 
lanes 8-10). Even the flow through fractions contained rTri a 12 in high quantity, 
although highly contaminated by bacterial protein (fig.36, lanes 3-7). 
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Recombinant Bet v 2 (fig.36, lane 2) was used as an indicator for the 
approximate position of rTri a 12. 
 
4. Characterisation 
Protein concentration was determined by BCA. An endotoxin test (LAL) was 
performed to determine the level of bacterial endotoxin contamination. N-
terminal sequencing was performed to confirm the correct sequence of the first 
five amino acids. Mass spectrometry confirmed the anticipated molecular weight 
and circular dichroism showed that the protein was folded correctly. To 
characterize the IgE binding properties of rTri a 12 IgE blot, IgE inhibition (with 
natural wheat seed extract) and IgE ELISA (rTria 12 & Tri a 19) were 
performed. 
 
 
 
After dialysis of purified rTri a 12, quantification 
was determined by BCA (for detailed procedure 
see chapter 4.1). As shown in figure 37 (lanes 
2&3), 1.3 and 2.6 µg of purified rTri a 12 (final 
batch) were analysed by SDS-PAGE (15%). In 
both lanes a band is visible at 14 kDa.  
 
 
 
 
Fig.37: SDS-PAGE (15%) of defined amounts of rTri a 12 post 
dialysis. Lane 1: protein marker; lane 2: 1.3 µg rTri a 12; lane 3: 
2.6 µg rTri a 12 
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Fig.38: CD spectra of rBet v 2 and rTri a 12 at temperatures ranging from 25°C to 95°C 
Structural integrity was investigated using circular dichroism. rTri a 12 showed 
intact secondary structures, as did rBet v 2 (birch pollen profilin) which served 
as a control protein. In contrast to birch pollen profilin, wheat profilin showed a 
higher degree of stability when exposed to higher temperatures. rBet v 2 
already lost its structural cohesion at 55°C, where as rTri a 12 retained some of 
its structure at the same temperature (fig.38).  
 
N-terminal sequencing revealed the sequence of the first five amino acids (initial 
methionine cleaved off): (M)SWKAY. This sequence matched exactly the 
published profilin amino acid sequence (fig.28, row 2). 
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Fig.39: mass spectrogram of rTri a 12 
Intact mass was determined by mass spectrometry. Compared to the theoretical 
mass of 14032 Da the intact mass was determined at 14031 Da (fig.39).  
Tryptic digestion was able to confirm 43% of the profilin sequence (fig.40). 
 
 
Fig.40: Mass analysis of rTri a 12 after tryptic digestion confirmed the amino acid residues shown with 
green background. 
 
 
 
 
Fig.41: IgE blot of rTri a 12; lane 1: protein maker; rTri a 
12 was recognised by specific IgE antibodies of a person 
allergic to profilin (lane 2). Normal human serum and 
buffer served as negative controls (lanes 3&4) 
 
An immunoblotting (IgE blot) experiment 
demonstrated the successful recognition of 
rTri a 12 by specific IgE from the patient’s 
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serum (specific IgE antibodies) allergic to profilin. NHS and buffer served as 
negative controls (fig.41). 
 
 
 
 
 
 
 
Fig.42: IgE inhibition blot with natural wheat seed 
extract; Untreated serum (specific IgE) recognised 
natural wheat profilin (lane 2). Treatment with rTri a 
12 successfully inhibited the recognition of natural 
profilin from wheat seed extract (lane 3). Also, rBet 
v 2 inhibited the recognition of natural profilin (lane 
4). Normal human serum and buffer served as 
negative controls (lanes 5&6). 
 
IgE inhibition with a natural wheat seed 
extract was performed to compare the 
IgE binding capability of recombinant 
and natural wheat profilin. 
Recombinant Bet v 2 served as 
positive control. NHS and buffer served as negative controls. Untreated (by rTri 
a 12 or rBet v 2) serum was able to recognize natural wheat profilin from the 
extract (fig.42; lane 2). Preincubating the serum with either rTri a 12 or rBet v 2 
resulted in a strong inhibition (fig. 42; lanes 3&4), with rBet v 2 showing a slighty 
less effective inhibition.  
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Fig.43: rTri a 12-IgE ELISA with wheat allergic patient’s sera 
 
An ELISA was performed to assess the IgE binding capability of recombinant 
wheat profilin. Eight sera from wheat allergic patients were tested, of which 
three reacted positively (fig.43; B209, B211, B212; 38% of sera recognised rTri 
a 12). 
 
To evaluate the role of wheat profilin in bakers’ asthma another ELISA was 
performed with sera from 25 wheat allergic patients (table 9). Eleven of these 
sera were obtained from persons with allergic reactions against wheat flour. 14 
sera where obtained from persons with a known allergic reaction after ingesting 
wheat containing products. 
13 patients were positively tested with SPT, 7 sera reacted negatively, and 5 
sera were not tested at all. CAP/RAST was performed for all patients (table 9). 
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Fig.44: rTri a 12-IgE ELISA with 13 sera of patients suffering from bakers’ asthma 
 
 
 
 
Fig.45: rTri a 12-IgE ELISA with 12 sera of patients suffering from wheat allergy 
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Sixteen out of 25 sera from persons with wheat related allergic reactions 
showed wheat profilin specific IgE (64% of patients recognised rTri a 12; fig. 
44&45). Of the 25 patients, 13 suffered  from bakers’ asthma. Nine sera out of 
13 showed rTri a 12 specific IgE (fig. 44; 69.23%).12 patients suffered from 
wheat food allergy. Seven sera out of 12 showed wheat profilin specific IgE 
(fig.45; 58.3%).  
The 25 sera were further investigated by IgE ELISA to screen for patients with 
an IgE reactivity towards Tri a 19, a major allergen in WDEIA. Only two 
individuals, both suffering from bakers’ asthma, showed specific IgE towards Tri 
a 19 (fig.46; 3115, 3243). 
Patients suffering from bakers’ asthma reacted more readily with rTri a 12 than 
patients suffering from wheat food allergy (69.23% vs. 58.3%). Also, patients 
suffering from bakers’ asthma showed a more powerful IgE reaction compared 
to wheat food allergics (average OD 405nm for bakers’ asthmatics: 0.199; 
average OD 405nm for wheat food allergics: 0.060). 
 
Fig.46: Tri a 19-IgE ELISA with 25 sera of patients suffering from either wheat allergy or bakers’ asthma; 
only 2 patients (3115&3243) suffering from bakers’ asthma showed specific IgE reactivity.
DISCUSSION 
86 
 
IV. DISCUSSION 
Allergy diagnosis and specific immunotherapy (SIT) are performed with crude 
extracts from the offending food. These extracts are often difficult to prepare, 
possess varying protein content, and during the extraction procedure allergens can 
be degraded. Therefore results, be it in diagnosis or in therapy, obtained with this 
extracts are of questionable quality [66]. Patients with strong reactions towards 
allergens are also at risk when tested with food extracts. 
Recombinant allergens are a way to circumvent this multitude of problems. Purified 
and well defined, they provide the necessary properties to diagnose allergies 
correctly and in a comparable fashion.  
Profilin is an ubiquitous protein, to which 10-20% of allergic patients are sensitized 
[83]. To what extent these sensitizations result in clinical symptoms is unclear [84]. 
Profilin is also the main agent of cross sensitization in pollen related food allergies 
[85, 21]. 
The aim of the study was to obtain enough recombinant wheat profilin, its 
characterisation on the molecular level, and to assess its IgE binding capability.   
A further goal was to obtain information on the sensitization patterns towards wheat 
profilin in patients suffering from wheat food allergy and bakers’ asthma.  
RNA was extracted successfully (fig.20&21). Following cloning and sequencing, the 
cDNA sequence of Tri a 12 was identified with a coding sequence of 396 bp using 
PCR with gene specific primers (fig.23&24). The total length of the deduced amino 
acid sequence consists of 131 amino acid residues (fig.28), a theoretical mass of 
14,032 Da, and an isoelectric point of 5.04. Protein alignments of Tri a 12 using 
ClustalW revealed high identities with profilins of  barley, timothy grass, and maize 
(fig.28). The DNA sequence of the obtained profilin showed deviations from the 
published sequence at eight positions (fig.27). At the amino acid level two different 
amino acid residues were observed (fig.28).  
Tri a 12 was cloned into the pET17b expression vector (fig.29-33) and expressed as 
a non fusion protein in BL21(DE3) E. coli cells. After lysating the cells using a french 
press, profilin was purified by affinity chromatography (fig.35). SDS-PAGE followed 
by Coomassie staining showed a band at the expected height of 14 kDa (fig.36). 
Recombinant Tri a 12 (rTri a 12) was identified by N-terminal sequencing of five 
amino acid residues (M)SWKAY (initial methionine was cleaved off). Mass 
spectrometry revealed an intact mass of 14,031 Da (without the starting methionine; 
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fig.39). A tryptic digest resulted in a 43% sequence identity (fig.40). Circular 
dichroism was performed to get information about the structural integrity of Tri a 12. 
At 55°C it starts to loose its structural cohesion (fig.38), at 95°C Tri a 12 is completely 
denatured. After a cool down to 25°C recombinant wh eat profilin was able to regain 
its structural integrity.  
To assess the IgE binding qualities of rTri a 12, IgE immunoblotting was performed. 
Recombinant wheat profilin was recognised by IgE antibodies of a profilin allergic 
person (fig.41). IgE inhibition with a natural wheat seed extract showed that rTri a 12 
possesses a comparable IgE binding capability to natural wheat profilin. Birch pollen 
profilin was tested alongside rTri a 12 as a positive control (fig.42). 
Recombinant wheat profilin’s role in wheat food allergy and bakers’ asthma was 
determined by an IgE ELISA with eight sera from the EUROPREVALL serum bank. 
Three out of eight sera showed a positive signal (37.5%; fig.43). This demonstrated 
the proposed minor role of profilin in wheat food allergy. 
Another series of Ige ELISA experiments with 25 sera provided by the Floridsdorfer 
Allergiezentrum (tab.9). 13 Sera were from patients suffering from bakers’ asthma 
and 12 sera from patients suffering from wheat food allergy were tested (fig.44+45; 
16 out of 25 (64%) showed specific IgE directed against rTri a 12. If the test results 
are divided into wheat allergics (fig.45) and bakers’ asthmatics (fig.44) a clear 
difference is visible. People suffering from bakers’ asthma showed a higher rate of 
positve signals (9 out of 13; 69.23%) as wheat allergics (7 out of 12;58.3%). Also the 
reaction was stronger in persons suffering from bakers’ asthma, the strongest signal 
from a person suffering from bakers’ asthma reached an OD405nm = of 0.7 (fig.44; 
serum nr. 1826), whereas the strongest signal visible in wheat allergics was OD405nm 
= 0.14 (fig.45; serum nr. 3261).  
These results indicate a more prominent role of wheat profilin in bakers’ asthma, 
which is a disease caused by inhalant allergens, compared to wheat food allergy, 
which is caused by ingesting the culprit food. 
Tri a 19, a major allergen in wheat dependant excercise induced anaphylaxis 
(WDEIA), was also tested in an IgE ELISA experiment (fig.46). Only 2 out of 25 sera 
tested, showed a positive result (fig.46; sera nr. 3115&3243).  
In summary it could be demonstrated that rTri a 12 has comparable IgE binding 
qualities as natural wheat profilin. It was also demonstrated, that wheat profilin is 
eagerly recognised by a clear majority (fig.44; 72,72%) of patients suffering from 
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bakers’ asthma, whereas a poor reactivity of wheat food allergics was observed 
(fig.45). 
To evaluate rTri a 12 role as a clinically relevant allergen, data regarding pollen 
sensitisation should be obtained and SPT should be performed to get in vivo test 
results. 
Recombinant wheat profilin (rTri a 12) will be subjected to the allergen library 
established in the EC-project 
EUROPREVALL (“The Prevalence, Cost and Basis of Food Allergy across Europe”). 
By the use of well-defined individual allergens, component-resolved diagnostics will 
be established and sera from a large number of food allergic patients (total = 2,000) 
from numerous clinical centres across Europe will be screened. Thus, comparable 
data on the prevalence of food allergy in Europe will be feasible in the near future.  
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V. ABBREVIATIONS 
In alphabetical order: 
 
AP  Alkaline phosphatase 
           APS  Ammonium persulfate solution 
 BCIP  5-Bromo-4-chloro-3-indolyl phosphate 
 BSA  Bovine serum albumin 
 CBB  Coomassie brilliant blue 
CD  Circular dichroism 
cDNA  Complementary deoxyribonucleic acid 
CIAP  Calf intestine alkaline phosphatase 
DBPCFC Double blind placebo controlled food challenge  
DEPC  Diethylpyrocarbonat 
DMSO Dimethyl sulfoxide  
DNA  Deoxyribonucleic acid 
DTT  Di-thio-threitol 
EAST  Enzymeallergosorbent test 
 EDTA  Ethylenediamine tetraacetic acid 
ECF-A Eosinophil chemotactic factor of anaphylaxis 
 ELISA  Enzyme linked immuno sorbent assay  
 FA  Formaldehyde agarose  
FPLC  Fast protein liquid chromatography 
GSP  Gene specific primers 
HMW  High molecular weight 
IUIS  International Union of Immunological Societies 
LB  Lysogeny broth 
LTP  Lipid transfer protein 
M-MuLV Moloney murine leukemia virus  
MOPS 3-[N-morpholino]propanesulfonic acid  
mRNA Messenger ribonucleic acid 
NBT  Nitro blue tetrazolium chloride 
NHS  Normal human serum 
OD  Optical density 
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PAF  Platelet activation factor 
PAGE  Poly acryl amide gel electrophoresis 
PCR  Polymerase chain reaction 
pI  Isoelectric point 
RAST  Radioallergosorbent test 
RNA  Ribonucleic acid 
RT  Room temperature  
RT-PCR Reverse transcriptase polymerase chain reaction 
SB  Sample buffer 
SDS  Sodium dodecyl sulfate 
SOC  SOB-Medium + glucose 
SPT  Skin prick test 
TAQ  Thermus aquaticus 
TBE  Tris borate EDTA 
 TBS  Tris buffered saline 
 WDEIA Wheat dependant exercise induced anaphylaxis 
 XGal  5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
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VII. ZUSAMMENFASSUNG 
 
Krankheiten die nach dem Verzehr von Weizenprodukten bzw. nach der Inhalation 
von Weizenmehl auftreten sind Zöliakie, Weizenallergie und Bäckerasthma. 
Eine weitere, jedoch selten auftretende Krankheit, ist die durch den Verzehr von 
Weizen mit nachfolgender körperlicher Betätigung ausgelöste Anaphylaxie (WDEIA). 
Diese vier verschiedenen Krankheitsbilder unterscheiden sich in ihren Symptomen 
und in ihrer Reaktion auf unterschiedliche Allergene. Ein potentieller Auslöser für 
Weizenallergie, WDEIA und Bäckerasthma ist Profilin aus Weizen. 
Ziel dieser Arbeit war es, Profilin (Tri a 12), ein Protein aus Weizen (Triticum 
aestivum) zu klonieren, als rekombinantes nicht-Fusionsprotein in E. coli zu 
exprimieren, zu reinigen und seine Eigenschaften zu untersuchen. 
Gesamt-RNA wurde aus Weizen (Cultivar Edison) isoliert und mittels PCR konnte die 
Tri a 12 cDNA kloniert und sequenziert werden. 
Die kodierende Sequenz besteht aus 396 Basenpaaren (inklusive Start/Stoppcodon) 
und wurde in den Expressionsvektor pET17b kloniert. Für die Expression bei 30°C 
wurden E. coli BL21(DE3) Zellen verwendet. 
Rekombinantes Tri a 12 wurde aus der löslichen Zellfraktion isoliert und mittels 
Affinitätschromatographie gereinigt. Tri a 12 besteht aus 131 Aminosäuren (inklusive 
Start-Methionin) und hat eine intakte molekulare Masse von 14,031 Da und einen 
isoelektrischen Punkt von 5,04.  
N-terminales Sequenzieren der ersten fünf Aminosäuren und Massenspektroskopie 
verifizierten die Sequenz von Weizenprofilin. Zirkuläre Dichroismus Spektroskopie 
zeigte, dass rTri a 12 nach Reinigung als gefaltetes Protein vorliegt und eine 
gemischte α/β-Sekundärstruktur besitzt. IgE Bindung wurde mittels IgE Immunoblot 
und  IgE ELISA untersucht. Hierfür wurden Seren von Patienten mit diagnostizierten 
allergischen Symptomen nach dem Verzehr von Weizenprodukten bzw. 
Weizenmehlinhalation verwendet. 
Tri a 12, ein Mitglied der Profilin-Familie, wurde identifiziert und charakterisiert. Es 
stellt nun ein weiteres Allergen dar, welches für allergen-spezifische Diagnose und 
zur Bestimmung der Kreuzreaktivität zwischen verschiedenen Profilinen verwendet 
werden kann.  
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VIII. ABSTRACT 
 
There are three major diseases caused by either wheat consumption or wheat flour 
inhalation: celiac disease, wheat allergy and bakers’ asthma. 
A fourth disease is the very rare wheat-dependant exercise induced anaphylaxis 
(WDEIA). These four diseases display different symptoms and are caused by 
different allergens. One potential causative agent is wheat profilin. 
 
Total RNA from wheat (cultivar Edison) was isolated and PCR with gene specific 
primers was performed. cDNA encoding for Tri a 12 was cloned and sequenced. The 
coding sequence consisting of 396 bp (including start- and stopcodon) was cloned 
into the expression-vector pET17b. E.coli BL21(DE3) was used as host strain for 
expression at 30°C. Recombinant Tri a 12 was isolat ed from the soluble cell fraction 
and purified by affinity chromatography. Tri a 12 has a deduced amino acid sequence 
of 131 amino acid residues (including initial methionine) and an intact molecular 
mass of 14, 031 kDa and an isoelectric point of 5.04.  
N-terminal sequencing of the first five amino acid residues and mass spectroscopy 
confirmed the expected wheat profilin sequence. 
Circular dichroism spectroscopy showed that rTri a 12 was expressed and purified as 
a folded protein since it displayed a mixed α/β-secondary structure. IgE binding 
properties were investigated by IgE immunoblotting and  IgE ELISA. 
Sera from diagnosed wheat allergic patients were used for the investigation of IgE 
binding properties. 
Tri a 12, a member of the profilin protein family, was identified and characterised. It 
represents another molecule suitable for component-resolved diagnosis and for 
defining cross reactivity among profilins. 
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